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- Photo diode array detector 
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GLC - Gas liquid chromatography 
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RR T - Relative retention times 
SPE - Solid phase extraction 
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Summary 
The necessity of developing broadly based in-house toxicology screening procedures and 
their associated databases in any department purporting to offer a toxicology service, 
cannot be overestimated. The development, in the past twenty years, of a number of 
different immunoassay techniques with which a large number of target compounds can 
be detected very selectively, all too often lulls the physician treating a drug overdose case 
into a false sense of security once a specific compound has been identified This is so 
because, once a drug has been identified which appears to account for the patient's 
condition, the search for other possible contributors is more often than not, abandoned. 
The aim of this study was to develop a screening procedure for neutral and acidic drugs 
in the urine of poisoned patients to complement the already existing gas chromatographic 
screening procedure for basic drugs. Sixty different substances were identified as a 
nucleus with which to launch the project. These substances were selected on the basis of 
their availability to the public and on data of overdose cases treated in this laboratory 
during the past twenty three years. 
Information on a large number of published screemng procedures for these type of 
compounds and the various techniques involved in their isolation, detection and 
identification, was collected initially. These techniques were subsequently- optimised 
with the aim to develop a combined high performance liquid chromatography / diode 
array detector / UV spectral database based screening procedure which is simple and can 
be performed rapidly at reasonable costs. The liquid-liquid extraction procedure for 
acidic and neutral drugs, with diethyl ether as organic solvent and a clean-up washing 
step with lead acetate solution, gave good recoveries and yielded chromatograms with 
little interference by endogenous compounds. 
The general applicability of this screening procedure in a senes of suspected drug 
• overdoses, has lead to the isolation and identification of a number of drugs added as 
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standards to the spectral database as well as some unexpected compounds which were 
subsequently added to the database. Metabolites of several drugs were also identified in 
the urine of patients in some of the case reports presented. The data on these 
compounds were likewise added and are still being added to the spectral library 
whenever new data become available during the treatment of overdose cases. The 
metabolite patterns of drugs obtained in this way are invaluable additions to the 
screening procedure as they contribute significantly to making the identification of 
isolated drugs unambiguous. 
The simplicity and speed of the developed screemng procedure, makes it ideal for 
toxicological screening since the whole procedure can be performed in under an hour. 
Because a simple liquid-liquid extraction procedure is used, the costs are less than 
normally encountered with solid phase extraction methods. Moreover, it is certainly 
much cheaper and faster than a series of immunoassay-based target analyses which 
would be needed to cover even a small fraction of the compounds which can be isolated 
and identified by this broadly based procedure. 
The results obtained in this study demonstrated that selective testing could have grave 
consequences for the patient. Commercially available quick tests for toxicology 
screening can be misleading because clinicians can get a false impression of the abilities 
oflaboratories rendering such services. This was illustrated in a number of case studies 
by using the screening procedure developed during this study. A good example is the 
case in which theophylline was found during an HPLC screening. On the basis of the 
patient's history the clinicians only requested target analyses for anticonvulsants of which 
two were actually found in the patient's plasma and of which one was at a concentration 
which could account for the patient's clinical condition. The high plasma level of 
theophylline assayed subsequent to theophylline being detected in the stomach content, 
could have been fatal. 
2 
© Central University of Technology, Free State
It can be concluded that this project yielded a comprehensive and versatile screening 
method and database for the identification of acidic and neutral drugs in urine. The data 
obtained during several of the case studies contributed information which was useful in 
the treatment of the patients involved. 
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Opsomming 
Die noodsaaklikheid vir die ontwikkeling van 'n omvattende binnenshuise toksikologiese 
siftingsprosedure en geassosieerde databasis in enige departement wat voorgee om 'n 
toksikologiediens te lewer, kan nie oorbeklemtoon word nie. Die ontwikkeling oor die 
afgelope twintig jaar van 'n verskeidenheid immunologiese bepalingmetodes, waarmee 'n 
groot aantal teikenverbindings baie selektief opgespoor kan word, sus die klinikus in die 
behandeling van 'n oordoseringsgeval in 'n valse gevoel van versekerdheid, wanneer 'n 
spesifieke middel ge[dentifiseer is. Wanneer 'n geneesmiddel wat moontlik die pasient se 
toestand kan verklaar, eers ge[dentifiseer is, word die soektog vir ander moontlike 
bydraende faktore dikwels nie uitgeskakel nie. 
Die doel van die studie was om ter aanvulling van bestaande gaschromatografiese 
siftingsprosedures vir basiese geneesmiddels, 'n siftingsprosedure vir suur - en neutrale 
geneesmiddels in die urien van vergiftigde pasiente te ontwikkel. Sestig verskillende 
substanse is ge[dentifiseer as 'n kern, waarmee die projek begin is. Die substanse is 
gekies op die basis van hulle beskikbaarheid aan die publiek en data van 
oordoseringsgevalle wat gedurende die afgelope drie-en-twintig jaar in hierdie 
laboratorium versamel is. 
Inligting oor 'n groot getal gepubliseerde siftingsprosedures vir hierdie tipe verbindings 
asook verskeie tegnieke betrokke in die isolasie, opsporing en identifikasie, is aanvanklik 
versamel. Hierdie tegnieke is voorts gebptimiseer met die doel om 'n gekombineerde 
hoe-verrigtings-vloeistof-chromatografie / dioderangskikkingsdetektor / UV-spektra-
databasis-gebaseerde siftingsprosedure, wat eenvoudig is en wat vinnig uitgevoer kan 
word teen 'n lae koste, te ontwikkel. Die vloeistof-vloeistof ekstraksieprosedure vir suur 
en neutrale geneesmiddels, met dietieleter as organiese oplosmiddel en 'n 
skoonrnaakprosedure met loodasetaat, het goele opbrengste gel ewer en 
chromatogramrne met min inrnenging deur endogene verbindings is verkry. 
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Die algemene toepasbaarheid van die onderhawige siftingsprosedure, in 'n reeks 
ondersoeke van die urien asook ander liggaamsvloeistowwe van pasiente wat opgeneem 
is vir die behandeling van vermeende geneesmiddeloordoserings, het aanleiding gegee tot 
die isolasie en identifikasie van verskeie geneesmiddels wat oorspronklik as standaarde 
tot die databasis gevoeg is, terwyl 'n aantal onverwagte nuwe verbindings bykomend tot 
die databasis gevoeg is. Metaboliete van verskeie geneesmiddels is ook in die urien van 
pasiente in sekere van die genoemde gevallestudies gevind. Die data van hierdie 
verbindings is tot die spektrumbiblioteek toegevoeg en sal deurlopend bygevoeg word 
wanneer nuwe data beskikbaar word gedurende die behandeling van 
oordoseringsgevalle. Die metabolietpatrone van geneesmiddels wat op die wyse bekom 
word, is waardevolle toevoegings tot die siftingsprosedure, omdat dit bydra tot die 
onomwonde identifikasie van die geisoleerde geneesmiddels. 
Die eenvoudigheid en spoed van die met ode wat ontwikkel is maak dit ideaal vir 'n 
toksikologiese siftingsprosedure, omdat die hele prosedure binne 'n uur uitgevoer kan 
word. Die metode behels 'n eenvoudige vloeistof-vloeistof ekstraksieprosedure, wat tot 
gevolg het dat kostes laer is as wat normaalweg met soliede fase ekstraksiemetodes 
ondervind word. Die metode is beslis baie goedkoper en vinniger as die reeks van 
imunologies-gebasseerde teikenbepalings, wat normaalweg nodig sou wees om selfs 'n 
klein fraksie van die verbindings, wat geisoleer en geidentifiseer kan word, te d.ek. 
Die resultate wat in die studie verkry is, het dan ook getoon dat selektiewe toetsing 
ernstige nagevolge vir 'n pasient kan inhou. Kommersiele beskikbare kitstoetse vir 
toksikologiesiftingsprosedures kan misleidend wees, omdat klinici 'n vals indruk van die 
vermoens van die laboratorium wat die dienste verskaf kan kry. Laasgenoemde is in 'n 
verskeidenheid van gevallestudies, aan die hand van die siftingsprosedure wat in hierdie 
studie ontwikkel is, geillustreer. 'n Goeie voorbeeld is die geval waarin teofillien tydens 
'n hoe-verrigtings-vloeistof-chromatografie sifting gevind is. Gebaseer op die pasient se 
geskiedenis, het die klinici slegs teikenanalises vir anti-konvulsante versoek, waarvan 
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twee werklik in die pasient se plasma gevind is. Een van die verbindings het 'n 
plasmakonsentrasie, waaraan die pasient se kliniese toestand toegeskryf kon word, 
weerspieeI. Die hoe plasmakonsentrasie van teofillien wat egter later bepaal is, nadat dit 
deur middel van die siftingsprosedure in die maaginhoud opgespoor is, kon fataal gewees 
het. 
Die gevolgtrekking kan gemaak word dat hierdie studie 'n omvattende en veelsydige 
siftingsprosedure en databasis vir die identifikasie van suur - en neutrale geneesmiddels in 
uri en opgelewer het. Die data verkry gedurende verskeie van die gevallestudies, het 
bygedra tot betekenisvolle inligting wat nuttig was in die behandeling van die betrokke 
pasiente. 
6 
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CHAPTER 1 
Introduction 
Among the many drugs which have entered the market, the number of analgesic and non-
steroidal anti-inflammatory drugs made available to the public during the past two 
decades has increased tremendously. Most of these drugs are available as over the 
counter preparations and are thus quite freely available to the public without 
prescription. Coupled with the fact that analgesic drugs are known to be misused to a 
large extent by the general public, the frequency with which these drugs are identified 
during overdose caSes has increased; be it as the main component of the overdose or 
merely as a complicating accompaniment with the overdose of another drug substance. 
Additionally and in general, over the counter drugs are carelessly handled in many 
households, are often stored within reach of children and are thus implicated in a large 
percentage of the unintentional drug overdose cases seen by casualty departments. 
When a doctor is confronted with an overdose, an attempt must be made to determine 
the kind of drug or substance involved, as soon as possible. The development of a more 
specific target screening procedure for these drugs as an adjunct to the existing general 
thin layer chromatographic screening and the basic drug gas chromatographic screening 
procedures, was therefore considered to be desirable. 
In the light of the proceeding introductory remarks, the more specific purpose of this 
study was to develop a suitable screening procedure for the detection and identification 
of analgesic and non-steroidal anti-inflammatory drugs, available on the market in the 
Republic of South Africa, in the urine of poisoned patients. 
Rapid and accurate analysis of the body fluid samples of the poisoned patient requires 
intensive investigation techniques, especially in the case of multiple drug ingestion. 
Various analytical techniques are available for the analysis of such samples. In general 
the determination of drugs in biological matrix is divided into two stages namely: 
7 
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1. sample preparation and isolation followed by 
2. the actual identification of the drug. 
The isolation or recovery of drugs from the biological matrix can be achieved by various 
extraction techniques, for example: 
1. Liquid-liquid extraction, which has an acceptable recovery, is relatively cheap and 
can be rapid depending on the circumstances and the sample matrix. 
2. Solid phase extraction which, despite being a powerful tool, is limited because of 
the costs involved as well as the nature of the biological samples used; for instance 
in forensic work, whole blood tends to clog the solid phase extraction column. 
Because of their potential for selectivity, most solid phase extraction methods have 
been focused on individual drugs or groups of related drugs and only recently 
serious attempts have been made to extend the use of solid phase extractions to 
class-independent screening procedures in toxicological work. 
Except for immunoassays, most analytical toxicology procedures require isolation of the 
drugs from either an aqueous or biological matrix (usually plasma or urine) prior to the 
actual measurement. A very important aspect of any isolation procedure is the extent of 
the recovery of the analyte from the matrix since this will often determine . whether a 
component will be detected; especially when one deals with some of the modern potent 
drugs. Most published analytical procedures usually contain a report of recovery and in 
this respect all the extraction procedures mentioned earlier have been reported on in the 
publications cited. Since no single extraction procedure can be singled out as being the 
preferred procedure for all drugs the choice of isolation procedure used is often dictated 
by parameters such as availability, convenience, speed etc. In the case of emergency 
toxicology, for instance, where one often deals with overdoses of drugs, speed of 
isolation is more often than not, more important than good recovery. 
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The determination or identification of the substance, once it has been isolated, can be 
done by a variety of techniques in which chromatography plays the most important 
central role. 
Since a very high percentage of drugs contain nitrogen, gas chromatography (GC) offers 
high sensitivity and selectivity in drug analysis especially when a nitrogen phosphorus 
selective detector (NPD) is used. However, acidic drugs, and also the more polar drugs, 
do not chromatograph well on GC, and derivatization to form a less polar and more 
volatile compound is often necessary. The advent of HPLC offers another option in the 
analysis of these drugs. 
In a relatively short time HPLC has become a widely used, fully established and efficient 
analytical technique. The rapid development is attributable to the progress in column and 
instrumental technologies. With well-designed data handling systems HPLC has been 
greatly expanded and is particularly suitable for drugs which are polar, for example 
analgesic and the non-steroidal anti-inflammatory drugs. The development of diode 
array detectors and the introduction in 1982, by Hewlett-Packard, of the world's first 
commercially available diode array detector, has been one of the most important 
advances in HPLC in the last 10 years because it tremendously increased the scope for 
identifying substances eluting from the column. The improvement of HPLC pumps has 
also led to better chromatography and the achievement of more reproducible f10wrates 
meant that more reliable retention times could be achieved. 
However, reproducibility of retention time data between laboratories is recognised as 
being a problem in HPLC methodology because of small changes resulting from local 
conditions e.g. water, reagent quality, columns etc. For these reasons it is recommended 
that individual laboratories prepare their own database of retention times and UV 
spectra. 
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Because of the nature of the drugs to be identified (i .e. mostly acidic and neutral 
compounds), it was decided to opt for screening of the drugs in urine using a single 
liquid-liquid extraction while incorporating a simple clean-up step followed by gradient 
HPLC with diode array UV detection. It was postulated that this HPLC-based 
toxicological screening prosedure with accompanying extraction procedure, as 
developed in this study, would prove to be a reliable procedure to identify neutral and 
acidic drugs in the urine of poisoned patients. 
10 
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CHAPTER 2 
Literature Review 
Traditionally toxicological extracts were screened for non-volatile organic compounds by 
a tedious process of systematic colour and crystal tests (Steward and Stolman, 1961). 
Ultraviolet absorption and its change with pH have been used extensively as a systematic 
approach to the presumptive identification of compounds to which they are applicable. 
Serious limitations are imposed on this procedure because, for a mixture of components, 
a composite spectrum for all absorbing compounds is obtained. 
Paper chromatography has also been used successfully to screen tissue extracts (Steward 
and Stolman, 1961). In the latter case the resulting fractions were traditionally located 
and characterised by an array of chromogenic reagents and could be eluted, depending 
on previous treatment, for further examination. Many different chromatographic solvent 
systems were, however, required for adequate separation within the acidic, basic, and 
neutral fractions that resulted from toxicological extractions. 
During the 1960's, thin layer chromatography (TLC) replaced paper chromatography as 
an extremely valuable adjunct for detection of drugs in screening procedures, are 
presently in use and will probably still continue to be used for a long time to come. TLC 
is rapid and ideally suited for drug identification. It is a technique which can be easily 
introduced for only a small capital outlay and its application to the analysis of urine 
specimens is particularly commendable since in some cases characteristic spot patterns 
are produced by the drugs and their metabolites. The literature abounds with drug 
screening procedures based on this technique with the most extensive compilation of 
data useful to the analytical toxicologist being the second, revised and enlarged edition of 
"Thin-layer Chromatographic Rf Values of Toxicological Relevant Substances on 
Standardised Systems". The latter is a special issue of the TIAFT Bulletin designated as 
Report XVII of the DFG Commission for Clinical-Toxicological Analysis and prepared 
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under the auspices of the Committee for Systematic Toxicological Analysis of TIAFT by 
de Zeeuw et al. (1992 a) . 
Soon after the advent of gas chromatography (GC) in the 1950's, its remarkable utility 
was amply illustrated by its many applications to complex analyses as it was immediately 
applied by many toxicologists and analysts in other biomedical fields (Ettre, 1959). 
Initially the applicability of gas chromatography to routine analysis was complicated by a 
variety of column substrate materials and different operating conditions reported. This 
problem was addressed by Parker et al. (1963) who described a gas chromatographic 
method for the screening of toxicological extraction residues for alkaloids, barbiturates, 
sympathomimetic amines, and tranquillisers. Two Carbowax 20 M (alkaline and non 
alkaline) columns were compared to determine their usefulness in the screening of 
toxicological extracts and retention time data were given for 41 alkaloids 
chromatographed on an SE-30 column at five temperatures. In the same year Kazyak 
and Knoblock (1963) presented gas chromatographic data on compounds of general 
toxicological interest with a discussion on the problems of application of this technique 
to routine analysis using SE-30 and QF-1 columns. GC became a cornerstone in many 
laboratories because it offered remarkable operational efficiency in the screening process 
and identification of negative analyses. 
Numerous publications supplying gas chromatographic reference data pertinent to 
toxicology followed but few, if any, were directly linked to a simple and systematic 
scheme of analysis. Finkle et al. (1971) presented a simple GC system for the 
identification of a wide range of materials encountered in forensic toxicology which 
formed the foundation of an efficient screening system. They used four columns and 
three liquid phases, complemented by a direct solvent extraction scheme designed to 
detect common poisons, drugs and human metabolites to a sensitivity of 2 Ilg/ml in 
blood, urine, and tissue specimens. Relative retention data for almost 600 different 
substances were tabulated in two tables, one being an alphabetical name index and the 
12 
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other a relative retention time index. Thus, one table provided reference GC information 
for any of the substances prior to the analysis while the other allowed tentative 
identification of unknown GC peaks. 
Automated drug analysers equipped with automatic liquid samplers and integrators on-
line with a data processor were soon developed by Solon (1972). The automatic liquid 
sampler and integrator allowed one to obtain extremely precise retention time and areas, 
thus allowing the operator to do a rapid qualitative and/or quantitative screen for 
compounds which were not completely resolved. The system was capable of screening 
urine extracts at the rate of one sample every six minutes. The data processor with the 
appropriate software added the capability of combining the results from several analysers 
into a single report. 
Owing to the work of Moffat et al. (1974) and Moffat (1975), it was soon generally 
accepted that dimethyl silicone phases such as SE-30 and OV-I provide optimum 
discriminating power and that measurement of retention indices Kovats (1958) 
"Retentionsindices aliphatischer Halogenide, A1kohole, Aldehyde und Ketone" is the 
technique of choice for substance characterisation as well as for the compilation of gas 
chromatographic data in a data bank and the exchange of those data between different 
laboratories. Schepers et al. (1982), extended the work done with retention indices of 
drugs on packed columns to capillary columns and also chose to work with temperature 
programmed runs to diminish analysis times. Presently the most extensive compilation of 
GC data useful to the analytical toxicologist is the third, revised and enlarged edition of 
"Gas Chromatographic Retention Indices of Toxicological Relevant Substances on 
Packed or Capillary Columns with Dimethylsilicone Stationary Phases". The latter is a 
special issue of the TIAFT Bulletin and designated as Report XVIII of the DFG 
Commission for Clinical-Toxicological Analysis prepared under the auspices of the 
Committee for Systematic Toxicological Analysis ofTIAFT by de Zeeuw et al. (1992). 
13 
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The development of more selective detectors, such as the nitrogen/phosphorus selective 
detector, has gone a long way in addressing the problems of differentiation between 
nitrogen-containing exogenous compounds and many endogenous non-nitrogen-
containing compounds such as lipids, fatty acids and metabolites of food substances 
excreted in urine. To increase the reliability of GC analysis even more, emphasis was 
soon placed on supplemental qualitative techniques such as infrared spectrophotometry 
(GC-FTIR) and mass spectrometry (GC-MS). Initially the additional expertise and 
expense incurred by these techniques limited their usefulness in situations calling for 
large workloads, but these limitations have now been overcome to a large extent by 
many commercially available instruments. The second, revised and enlarged edition of 
"Mass ' Spectral and GC data of Drugs, Poisons, Pesticides, Pollutants and their 
Metabolites" by Pfleger et ai. (1992) is representative of the best compilation of GC-MS 
data available to the analytical toxicologist at present. 
Prior to 1967, liquid column chromatography was considered as slow and inefficient. 
However, the modernised technique now commonly known as high performance liquid 
chromatography (HPLC), has undergone dramatic changes and now rivals GC in speed 
of analysis and column efficiency. Initially there existed a common misconception that 
HPLC is less efficient than GC. Giddings (1965) was one of the first to recognise that 
the theory developed for GC was equally applicable, with minor modifications, to HPLC. 
The theory indicated that by using high pressures and very small particles, HPLC could 
rival GC both in speed and resolving power. In the case of GC, long columns can be 
used to increase the number of theoretical plates. The much lower permeability of HPLC 
columns, due to the very small particle size and the much higher viscosities of liquids, 
places a severe limitation on the column length but this is more than compensated for by 
the greater selectivity of this mode of separation; very difficult separations being 
achievable even with relatively short volumes. The greater selectivity is achieved 
through the choice of mobile phase, solvent programming and variations in the 
separation mechanism; i. e. adsorption, ion exchange and partitioning. 
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An important benefit of the application of the above mentioned theory was a unification 
of the practice of liquid chromatography. Modern HPLC equipment is similar for all 
forms of liquid chromatography and is equally usable for adsorption, partition ion 
exchange and gel chromatography. The most decisive feature of current HPLC is the 
use of highly sensitive as well as selective detectors. Initially the refractive index monitor 
and the ultraviolet (UV) spectrophotometer were the most popular but there are many 
principles on which detection may be based, and these have been and are still being 
extensively researched and exploited. Klatt (1979) published the first report of an 
isolation technique for unresolved peaks based on a rapid scanning multiwavelength 
detection system interfaced with a microcomputer. At the time the system was very 
costly and required a high degree of skill . In the five years following this publication, the 
cost of microcomputers and photodiode arrays were drastically reduced and became 
readily available. Multiwavelength UV detectors with up to 256 and more element 
photodiode arrays became commercially available during that time and attracted more 
chromatographers because they offered great advantages for qualitative analysis. HPLC, 
using gradient elution and photo diode array detection, was quickly adopted by many 
toxicologists as an extremely useful drug screening procedure for specific classes of 
drugs. 
Since it was the aim of this project to develop and set up an HPLC screening procedure 
with diode array detection for neutral and acidic drugs in urine samples from suspected 
poisoned patients, this literature survey will further concentrate, in more detail, on this 
aspect of drug screening. Emphasis was placed on the HPLC equipment used as well as 
the extraction and recovery of screened drugs. 
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2.1 HPLC Equipment 
An excellent review of multielement detectors was published by Talmi (1975). The 
classical silicon photo diode linear array, manufactured by Reticon, was the first detector 
marketed successfully. The development of two linear photodiode array spectrometers 
based on this array and used as detector systems in automated liquid chromatography, 
was described by Dessy et al. (1976 a). The first system involved a minimum 
configuration involving a microprocessor and a linear photodiode array acting as a rapid 
scanning single beam UV!VIS detector. This instrument could monitor up to eight single 
wavelengths. It plotted the absorption at the selected wavelengths as a function of time 
on a standard x/y plotter and could take a complete spectrum about every five seconds. 
The second system was designed around a large minicomputer system and was intended 
for pattern recognition work focusing on metabolite characterisation, isolation and 
identification. It was capable of taking 20 spectra/second in a dual-beam mode. 
In a similar vem another new mini-computer automated linear photodiode array 
spectrometer system for high-resolution liquid chromatography was developed by Dessy 
et al. (1976 b). This third generation multiwavelength array spectrometer was developed 
as a detector for high-resolution liquid chromatographic characterisation of metabolites. 
The design included a mini-computer, a matched pair oflinear photodiode (256 element) 
arrays, holographic ruled gratings, fibre optics, flow cells, and a high-intensity xenon 
light source. The resolution could be independently adjusted in the spectral range of 200 
- 800 nm. This system was used for the separation and characterisation of the 
metabolites of a carcinogen, 4-ethylsulfonyl-I-naphthalenesulfonamide. 
A rapid scanning diode array as a multiwavelength detector in liquid chromatography 
was described by Milano et al. (1976). They demonstrated how first derivative spectra 
can be gainfully utilised in a unique way to maximise the information obtained from this 
detector. The detector consisted of a low volume flow cell and real time signal 
averaging of the spectra, allowed operation at 0.005 a.u.f.s. with noise levels of 0.0005 
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a. u. peak to peak. The authors demonstrated that photodiode array detectors can allow 
operation with the sensitivities needed in modern LC. The availability of spectra rather 
than absorbency at a single wavelength allows better identification and quantitation of 
the solutes. This additional information can also be used for deconvolution of 
overlapping peaks by plotting absorbance or first derivative absorbance chromatograms 
at various wavelengths. 
The performance of a silicon target vidicon tube as a multi wavelength detector for liquid 
chromatography was discussed by Mc Dowell and Pardue (1977). The rapid scanning 
spectrometer used in this work was based on a silicon diode array vidicon camera tube 
and a magnetic focus and deflection assembly. This device covered a spectral range from 
about 200 nm to above 800 nm and permitted scan repetition rates of up to 100 scans 
per second. The most serious limitation of the vidicon detector system used in this work 
was the photometric drift which resulted from the single beam operation. 
The use of a rapid scanning diode array spectrometer for enhanced sensitivity via first 
derivative chromatograms was reported by Milano and Grushka (1977). They compared 
the sensitivity of the absorbency and first derivative measures using data previously 
collected for mixtures of benzene, benzyl chloride, and anisole. The results indicated that 
the use of first derivative detection in liquid chromatography did not only allow 
deconvolution of overlapping peaks, but also reduced the noise due to lamp fluctuations. 
Molnar and Horvath (1977) separated over a hundred acidic constituents present in 
urine. A high-pressure liquid chromatograph with a variable wavelength UV detector at 
280 nm or alternatively a fluorescence detector at 260 nm excitation and 340 nm 
emission wavelengths, was used in gradient elution mode. The constituents were 
separated within 30 min. by using a 5-~m octadecyl-silica column, with the gradient 
elution increasing the acetonitrile concentration in dilute aqueous phosphoric acid 
solution at 70°C. This study demonstrated that many low-molecular-weight constituents 
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of physiological fluids can be separated faster and more efficiently by microparticular 
non-polar stationary phases than ion-exchange resins employed conventionally. 
Milano et al. (1978) described the characterisation of the photo diode array detector in 
liquid chromatography. In order to access the viability of the photodiode array detector, 
its noise characteristics and linear range were studied. It was found that, at worst, the 
peak noise was ± 0.001 a. u. The detector was found to have a linear range between 2 x 
103 and 6.5 x 103 depending on the wavelength. The linearity of the detector was 
determined with a mixture of three components namely naphthalene, pyrene and 
benzopyrene. A mixture of benzene, toluene, p-xylene and mesitylene was used in the 
study of deconvolution and quantitation of overlapping peaks. The photo diode array 
detector was found to be linear over a wide range of absorbances with noise 
characteristics roughly the same as those of other commercial detectors and the vidicon 
detector. Some problems with the presented system was that stability needed to be 
improved and that stray light tended to be relatively high with array detectors, as filters 
and double monochromators cannot be used. 
A simultaneous multiwavelength detection system for liquid chromatography which 
consisted of a rapid-scan spectrometer with a UV silicon vidicon target as radiant energy 
detector, was used in a study by Klatt (1979). He described algorithms required for real-
time data processing capabilities. The use of this detection system to qualitatively assess 
compositional changes in coal derived oil as a function of process, as well as the 
limitation of the system and required improvements, were discussed. The results 
presented indicate that the simultaneous multiwavelength detection system possesses 
numerous and unique capabilities. However, three principal limitation are apparent. 
First, the detection limits are poorer than conventional single wavelength monitors. The 
second limitation concerns the cost of the system and thirdly a skilled operator is 
required in order to obtain the maximum value from a simultaneous multiwavelength LC 
detector. 
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While work on the diode array detectors was progressing, other developments in drug 
screening techniques also progressed at a rapid rate. A combination of TLC,GLC and 
HPLC for the rapid detection of drugs and related compounds was compiled by Daldrup 
et al. (1981). Almost 570 substances were tested by 8 different chromatographic 
methods. In the case of the HPLC procedure a UV detector at 220 nm was used and an 
isocratic mobile phase consisting of acetonitrile and phosphate buffer adjusted accurately 
to pH 2.30 was the preferred mode. 
A review of progress in the field of multichannel detection in column and thin-layer 
chromatography was presented by Fell et al. (1983 a) . Some novel applications for a 
computer-based linear photodiode array UV-visible spectrophotometer for detection in 
high-performance liquid chromatography, computer-aided methods for simultaneous 
monitoring of the elution profile at three wavelengths with automatic peak detection and 
capture ofUV spectra for diacetylmorphine and its principal metabolites and degradation 
products were either discussed or described. The authors found that the optical 
multichannel detector offers a rapid and versatile approach to detection in HPLC and 
TLC. By combining retention time data with rapidly scanned spectra captured during 
elution, drugs, their degradation products and metabolites can be characterised with 
greater specificity. Peak homogeneity can be examined by use of absorbency ratio and 
qualitative features can be enhanced. 
Novel techniques for peak recognition and deconvolution by computer-aided photo diode 
array detection in high-performance liquid chromatography were also examined by Fell et 
al. (1983 b). Digital algorithms for manipulating spectrochromatographic data, obtained 
by means of photodiode array detectors, were tested for peak purity and for their 
quantitative performance. Two model systems noscapine and papaverine, and the red 
pigments R 112 and R3, were studied. The absorbency ratio plotted as function of time 
performed less well in recognising peak overlap than the second derivative of the elution 
profile. Spectral deconvolution with a "dummy" linear absorbency standard, and a non-
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absorbing reference wavelength, permitted the elution profiles of both model systems to 
be completely resolved. This method revealed the elution profile of an unknown, closely 
overlapping peak in a sample containing papaverine and noscapine. 
On-line screening for urapidil and metabolites in dog urine by high-performance liquid 
chromatography with a diode array UV detector was achieved by Zech et aI. (1983). 
Because of the similarity of the metabolite spectra to the spectrum of the parent 
compound, selection was based on absorption ratios. They found that comparison of up-
slope, apex and down-slope spectra is a convenient way of testing for peak purity. 
In a study by Chan and Chan (1984) an HPLC was fitted with a programmable UV 
detector, and was used for the analysis of acidic and neutral drugs. The analytical column 
was a reverse-phase Hypersil ODS 5~m, 200mm x 4.6mm column. A phosphate buffer 
with a pH of 3.2 was used as a mobile phase and a gradient elution programme with 
acetonitrile was chosen. The relative retention times remained fairly stable and the initial 
screening procedure was routinely confirmed by gas chromatography, colorimetry and 
UV spectrophotometry. The authors were able to screen for all 40 drugs described when 
their concentrations in blood were in the toxic range. 
Hoshino et al. (1984) published results on the use of a photo diode array detector to 
identifY unresolved peaks. He built a muItiwavelength UV detector with a 32-element 
photodiode array and a data processor and used it for the quantitative isolation of poorly 
resolved chromatographic peaks. He further used a mathematical technique for 
simultaneous muIticomponent analysis of UV -spectra in order to develop computer 
software for the determination of unknown and hidden components. Three-dimensional 
chromatographic data was computed by a data processor and then stored on a floppy 
disk. The results obtained were compared with those obtained by conventional 
perpendicular dropping and tangential-skimming methods. Recoveries achieved by the 
new method were 100.7 and 101.1 % while those achieved by the conventional methods 
were 89.9 and 1l0.1%. 
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However, the identification of unknown drugs during drug screening procedures does 
not depend only on the detector. The extraction of the drugs from complex matrices into 
suitable solvents in which the drug could be further purified and enriched relative to the 
co-extracted endogenous components, is equally important and so are the many 
possibilities of utilising the unique selectivity ofHPLC. 
The analysis of antipyretics using semimicro columns (150 x Imm I.D.) was studied by 
Matsushima et al. (1985). The columns used were octadecyl silica and styrene-
divinylbenzene porous polymer. The analyte was dissolved in 80% aqueous acetonitrile 
for the ODS silica column and in methanol for the porous polymer column. Seven 
antipyretic drugs were chromatographed with a mobile phase of acetonitrile and water 
(25 :75) on the ODS column. With the porous polymer column three mobile phases were 
used, namely methanol, methanol containing 1 % acetic acid and methanol containing 1 % 
aqueous ammonia. The methanol containing 1 % aqueous ammonia was most suitable for 
the separation of a mixture of antipyretics. Xanthine drugs were also separated with the 
same mobile phase. An HPLC with a UV monitor operating at 254nm was used. The 
results described indicate that semimicro columns can be used for the separation of 
antipyretic agents. 
A new method of separation and identification of aromatic and nitrogen-containing acids 
in urine was presented by Ramnaraine and Tuchman (1985). Fifty-seven different acids 
were separated by reversed-phase HPLC. Detection and identification of the acids by 
UV spectra using a photodiode array detector (DAD) were demonstrated. They found 
that this method cannot replace the use of GC in metabolic profiling but that it is a 
complementary technique for compounds which cannot be determined by GC. 
Stevens and Gill (1986) used three eluents to chromatograph analgesics on an ODS silica 
column. The eluents were prepared by mixing aqueous potassium dihydrogen phosphate 
with formic acid and isopropanol. The three eluents had isopropanol contents of 1. 7%, 
15% and 35% respectively. This assay was carried out using an LC UV variable-
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wavelength detector operating at 244nm. Quantification was done using peak height 
ratio measurements with paracetamol as an internal standard. This method proved to be 
useful for the identification and quantification of analgesics and anti-inflammatory drugs. 
Useful sample handling techniques for reversed phase HPLC in emergency toxicology 
were discussed by Van Damme et a!. (1986). Using a multichannel detector, the 
advantages of dilution as well as liquid and solid extractions were also compared by the 
authors. In this way they (Van Damme et a!., 1986) demonstrated the importance of 
sample handling in toxicological analyses in which reversed phase HPLC is used. 
Sodium dihydrogen phosphate buffer with the pH adjusted with acetic acid or phosphoric 
acid and with different percentages of acetonitrile was used as the mobile phase. Instead 
of dihydrogen phosphate the authors used sodium acetate in the chromatography of 
caffeine and theophylline. 
A sequential simplex procedure for the optimisation of mobile phase composition In 
HPLC, combined with multichannel detection, was developed by Wright et a!. (1987). 
An efficient stop criterion for automated simplex procedures, based on continuous 
comparison of the chromatographic response function attained with that predicted, was 
proposed by the authors . They concluded that multi-channel detection has a number of 
features which strengthens its use with sequential simplex optimisation. 
HPLC photodiode array UV detection for toxicological drug analysis was applied by Hill 
and Langner (1987). Retention data for 157 compounds in an acid HPLC system, and 
144 compounds in a basic HPLC system were listed. They also listed UV spectral data 
for 25 compounds of each system. For the analysis of acidic and neutral drugs, a Zorbax 
C8 column maintained at 31°C was used. Compounds were eluted using a linear solvent 
program of 0 to 100 % BfA in 30 min. of the following: Solvent A was 0.1 % (vfv) H3 
P04 and solvent B was CH3 CN : H20 (9 + 1) containing 0.1 % (vfv) H3 P04. The 
flowrate was 2.0 mVmin. Reference compounds were dissolved in methanol at a 
concentration of 500 l!g/ml and 10 to 40 l!1 of this solution was analysed. Retention data 
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were recorded and the UV spectra at the apex of the peaks were normalised and stored 
in a reference library. The study demonstrated that combining HPLC separation of drugs 
with UV detection and computer matching of spectra can be an effective analytical tool. 
Thirty-seven selected acidic and neutral drugs were analysed by Bogusz and Aderjan 
(1988) by means of HPLC with a two step gradient elution. Nine different ODS silica 
columns were evaluated in this study, and the retention index values (Rl) were 
calculated. A series of alkyl-arylketones were used for the calculation of the Rl values. 
The mobile phase, a mixture of phosphate buffer (pH 3.2) and acetonitrile was used to 
run a gradient. The solvent gradient was 10% acetonitrile at 0 minutes to 70% at 30 
minutes. All samples were analysed at 220nm and at ambient temperature. 
In the applied gradient elution, the relation between the carbon numbers of the alkyl-
arylketones and their capacity factor was linear. The Rl values for the examined drugs 
were therefore calculated using k' values. Standardisation of the retention data by Rl 
alone did not reduce the intercolumn variability of the nine columns tested. The Rl 
values were then corrected with a method described in an earlier publication by Bogusz 
(1987). After correction the Rl values improved the comparability of the different 
columns and also increased the accuracy thereof. The authors suggest that when this 
method is used, the results obtained by HPLC in all laboratories should be comparable. 
Traditionally, the optimisation of separation conditions has always been performed by 
trial -and-error experiments which rely on the experience and intuition of the 
investigator. However, when an analysis requires a rapid response, this procedure 
cannot be relied upon. Computer-assisted systems can decrease the analysis response 
time, especially if the investigator is inexperienced in the field. In this regard a retention 
prediction approach, based on quantitative-structure retention relationships, has been 
described by Jinno et al. (1988) and Jinno et al. (1989). Their system determines the 
candidates of toxic compounds contained in the biological fluid by combining the 
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retention prediction concept and the UV spectral matching process. The actual 
components of the system were the following : 
1. A retention prediction system which predicted the retention times for particular 
compound groups such as polycyclic aromatic hydrocarbons, amino acids, small 
pep tides etc. 
2. An LC data base which provided the basic information for LC separations. 
3. An automated identification system which automatically identified compounds 
using the retention prediction concept. 
4. An automated optimisation system which optimised separation conditions for 
particular compound groups, such as amino acids, and offered minimum analysis 
time for maximum resolution for this compound groups and offered mlrumum 
analysis time for maximum resolution for the compound group desired. 
5. Multi-320 :chromatographic data station for the multichannel UV detection system 
which worked as the data processor to interpret the information obtained by the 
multichannel UV detector. 
6. UV spectral data base system which stored UV spectra published in the literature. 
The UV data base was used for the spectral matching process to identify the 
components separated by the liquid chromatograph. 
The expert system was constructed on an NEC personal computer PC 9801-VX2 16 bit 
on a MS-DOS operating system. The results of this study demonstrated that the system 
was useful where toxic compounds had similar UV spectra as well as similar retention 
times. 
In the chromatography of 23 diuretics by Cooper et at. (1989), an HPLC equipped with a 
diode array UV detector was used. This instrument was linked to a data system. The 
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retention prediction concept and the UV spectral matching process. The actual 
components of the system were the following: 
1. A retention prediction system which predicted the retention times for particular 
compound groups such as polycyclic aromatic hydrocarbons, amino acids, small 
peptides etc. 
2. An LC data base which provided the basic information for LC separations. 
3. An automated identification system which automatically identified compounds 
using the retention prediction concept 
4. An automated optimisation system which optimised separation conditions for 
particular compound groups, such as amino acids, and offered minimum analysis 
time for maximum resolution for this compound groups and offered mirumum 
analysis time for maximum resolution for the compound group desired. 
5. Multi-320:chromatographic data station for the multichannel UV detection system 
which worked as the data processor to interpret the information obtained by the 
multichannel UV detector. 
6. UV spectral data base system which stored UV spectra published in the literature. 
The UV data base was used for the spectral matching process to identify the 
components separated by the liquid chromatograph. 
The expert system was constructed on an NEC personal computer PC 9801-VX2 16 bit 
on a MS-DOS operating system. The results of this study demonstrated that the system 
was useful where toxic compounds had similar UV spectra as well as similar retention 
times. 
In the chromatography of23 diuretics by Cooper et aI. (1989), an HPLC equipped with a 
diode array UV detector was used. This instrument was linked to a data system. The 
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extracts were injected onto a Hewlett-Packard Hypersil ODS C 18 column or a Hewlett-
Packard LiChrosorb RP-18 column. The same gradient mobile phase was used for both 
columns. The mobile phase Solvent A was a phosphate buffer (pH3) containing 
propylamine hydrochloride. Solvent B was acetonitrile. Solvent B was increased from 
15% at 2min. to 80% at 20min. The diode array detector was set to monitor the signal 
at 230nm and 275nm. 
Diode array detection of 100 basic drugs and metabolites was studied by Logan et al. 
(1990). The HPLC analysis was performed using a gradient pump system (Varian) 
operated at 1. 5ml/min. , with a IOfll loop valve injector. The column was a Hibar 
Lichrospher 100 CH-8. A UVIVIS diode array detector with a chemstation was also 
used. The eluent was monitored at 200nm and full spectra were recorded from 190 to 
400nm for each peak. The initial mobile phase was composed of 10% acetonitrile in 
0.05M, pH 3.2, potassium phosphate buffer. This was increased to 50% over 15min., 
and the final composition was maintained for 5min. The sensitivity of the diode array 
detector was less than that of single wavelength instruments. With most of the 
extractions almost 100% recovery were achieved. 
An HPLC gradient elution system for general toxicological screening was developed by 
Bogusz and Wu (1991). The use of a diode array detector with library software allowed 
storage of retention parameters, UV spectra, and peak quality parameters. The retention 
indices of 225 substances were measured using the I-nitroalkane scale. The 225 
substances examined included therapeutic drugs, drugs of abuse and pesticides. The 
following instruments were used: A quaternary pump, an autosampler and a diode array 
detector with Chemstation software (all from Hewlett-Packard). A Supersphere IORPI8 
column was used with the following elution gradient: acetonitrile-buffer 0-70% over 30 
minutes and then 5 minutes at 70%. The buffer used was triethylammonium phosphate 
1. OM, pH3. O. All the experiments were performed at ambient temperature. The 
absorbance at 220nm was monitored as a pilot signal, and the UV spectra were stored. 
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I-Nitro-octane was added to each sample as indicator of gradient conditions. The RI 
values of substances were calculated against corresponding I-nitroalkanes. 
Autopsy blood was extracted using direct ethyl acetate extraction at pH4.6, dried under 
nitrogen, and reconstituted with 50~1 methanol. The applied HPLC system proved its 
usefulness in routine work, enabling identification of substances on the basis of two 
parameters namely retention index and UV spectra. 
The following chromatographic equipment was used in a class-independent drug screen 
in forensic toxicology using a photo diode array detector described by Drummer et al. 
(1993). The liquid chromatograph consisted of two constant flow pumps, a gradient 
mixing chamber, an auto-injector, a system controller and a photodiode array detector 
(Shimadzu Instruments), with a PC-AD computer. A back-up tape drive, an additional 
UV detector operating at 230nm, and an integrator/plotter were connected in series after 
the photo diode array detector. The photo diode array detector operated in a I-nm band-
pass mode monitoring light from 195 to 650nm. The analytical column was a Spherisorb 
S5 ODS-2 column. The mobile phase consisted of 10% acetonitrile in 10mM potassium 
phosphate buffer, pH3. I (pump A), and 60% acetonitrile in 10mM potassium phosphate 
buffer, pH3.1 (pump B). Gradient conditions were the following: Isocratic at 0% pump 
B for I minute, linear gradient to 50% pump B over 5 minutes isocratic at 50% pump B 
for 20 minutes, then linear gradient to 100% pump B over 10 minutes, followed by a 
hold at 100% pump B for 10 minutes. The total run time was 46 minutes and the flow 
rate 1.0mllmin. The assay was capable of detecting and identifYing therapeutic and toxic 
amounts of a large number of different classes of drugs and has been successfully used to 
screen over 1000 postmortem blood specimens. 
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2.2 Extraction 
The recovery of the analyte from the available biological sample is one of the crucial 
steps in analytical work. Various techniques to achieve this are available but each of 
these techniques has its own advantages and pitfalls. 
A popular extraction procedure which has been in use for many years is the liquid-liquid 
extraction as described by Street (1962). This is used for the extraction of alkaloids, 
neutral and acidic poisons in human tissue. After initial precipitation of proteins with hot 
tungstic acid, the principle underlying the procedure is to change the pH of the aqueous 
phase at different stages of the extraction process in order to separate the different 
compounds into various fractions which are then applied and separated by paper 
chromatography. The aim of this procedure is to separate the basic alkaloids, neutrals 
and weak acids for identification on paper chromatography. 
Goldbaum and Domanski (1966) described a method for the extraction of neutral drugs 
in biological samples. The problems of impurities, mostly neutral fats, were overcome by 
using hexane in the final extraction step, to get rid of all hexane soluble impurities, 
including neutral fats. They used gas chromatography for the identification of the neutral 
drugs by means of relative retention times. 
Extraction procedures in chemical toxicology with separation by distillation, solvent 
extraction and the use of ion-exchange resins of drugs from aqueous solutions were 
discussed by Tompsett (1968). Among the organic solvents discussed were chloroform, 
ether, ethyl acetate, benzene, heptane, and some mixtures as well. Most of the drugs 
examined in this study possessed high extinction UV spectra and an UV 
spectrophotometer was used to assess the recoveries of the different drugs tested by 
distillation and solvent-extraction procedures. 
The rapid analysis of a large number of urine samples for drugs was reported by 
Goldbaum et al. (1972). The method utilised gas-liquid chromatography, as well as a 
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spectrofluorometric procedure in the final analysis of the samples. The isolation 
procedure used to separate the basic, acidic and neutral drugs was a liquid-liquid 
extraction procedure. This procedure permitted the isolation of various drugs with a few 
manipulative steps. By adjusting the urine to pH 9 and extracting with a mixture of 5% 
isobutanol in chloroform, basic, acid, and neutral drugs were extracted into the organic 
phase from which basic drugs were back-extracted with 0.1 N H2S04 and acid drugs 
with 0.75 N KOH leaving the neutral drugs in the organic phase. 
An uncomplicated method of analysis for a variety of drugs subject to abuse and 
accidental overdose was published by Sine et al . (1972). Sample preparation involved 
serum extraction and aqueous dilution techniques which were followed by gas-liquid 
chromatographic analysis. For the extraction of acidic drugs, 0 1 mI concentrated HCl 
was added to 3 ml of the patient's serum and for the neutral extraction 3 ml of 0.1 M 
phosphate buffer pH7.4. Chloroform was used as extraction solvent. Drug recoveries 
ranged from 68 % to 100 %. 
The rapid separation of urinary acids by HPLC was studied by Molnar and Horvath 
(1977). The sample was saturated with NaCl and the pH of the supernatant was adjusted 
to 13 . Ethyl acetate was used as organic solvent to remove neutral and basic organic 
compounds. The aqueous phase was then adjusted with concentrated HCl to pH 1 and 
the organic acids extracted with ethyl acetate. After evaporation to dryness in· a nitrogen 
stream, the residue was redissolved in 1 M HCl for injection on the HPLC. The high 
sensitivity and speed of analysis, and the excellent reproducibility suggested that this 
technique might be useful to obtain metabolic profiles in routine clinical work. 
Berry and Grove (1973) made use of a liquid-liquid extraction procedure to extract 
drugs commonly involved in poisonings. They suggested a back-extraction procedure 
for stomach contents to get rid of fats, which normally give problems when a direct 
organic extract is spotted on a TLC plate. However, when employing a back-extraction, 
care should be taken to see whether neutral drugs remain in the chloroform layer. They 
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suggested that for neutral drugs a urine sample should be used and only a direct organic 
extraction should be made. For the identification of the different drugs they made use of 
thin layer chromatography (TLC) with various spray reagents . 
n-Butyl chloride was proposed by Foerster and Mason (1973) as an extractant in drug 
screening procedures. They suggested that n-butyl chloride be used instead of some of 
the other solvents commonly used in liquid-liquid extraction e.g. chloroform, ethylene 
dichloride; ethyl acetate, ether and hexane. They claimed that the final extracts obtained 
contained little interfering materials and were therefore suitable for analysis by gas 
chromatography. Three different extraction methods for basic, acidic and neutral drugs 
were performed with n-butyl chloride. 
A column chromatographic extraction technique involving extraction of acids in 
nonionised form and amines as ion pairs from the same sample was described by Ehrsson 
and Knapp (1974). The extraction of a biological sample was performed after the pH 
had been adjusted to pH 3 and 5 M sodium iodide was added to the sample. The mixture 
was filtered through a 0.5 g Celite 545 column on which the anaiytes were retained and 
from which they could then be eluted with water-saturated ethyl acetate. The whole 
extraction procedure, including the column packing was performed in under 10 minutes. 
Compounds as diverse as amphetamine and acetylsalicylic acid were recovered in yields 
close to 90% but the yield for morphine was only 7%. 
A procedure for extracting weak acidic, neutral and basic drugs from urine for thin layer 
chromatography by using an XAD-2 resin was described by Kullberg and Gorodetzky 
(1974). This extraction procedure was performed on 20 rn1 urine samples. Different 
concentrations of the various drugs under investigation were spiked in these urine 
samples. The percentage extraction was determined by means of radio isotope assay. 
The adsorption of morphine, amphetamine and phenobarbital from urine to the XAD-2 
resin was found to be dependent on the urine pH, urine flow rate through the column and 
the urine/resin ratio. Acetylsalicylic acid was not efficiently adsorbed. The reason for 
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this was probably because this compound is too acidic to be appreciably unionised at pH 
8.5. 
The distribution and recovery of 86 drugs from three different aqueous acidic or alkaline 
solutions into organic media was studied by Hackett et aL (1975). They also made a 
special study of the efficiency of the back-extraction process, i.e. the extraction from the 
organic phase into acidic or alkaline aqueous media. The three different single extraction 
procedures for neutral, acidic and basic drugs were performed with HCVchloroform, 
back-extracted with 0.45 M NaOH, Na2C03/chloroform back-extracted with 1.8 M 
H2S04, and Na2C03/ether back-extracted with 1.8 M H2S04. The results from this 
investigation enabled each system to be evaluated according to the efficiency of the drug 
recovery from either aqueous or organic solutions. They suggested that when urgency is 
an important factor, such as in cases involving a possible overdose, the slightly lower 
recoveries from a single extraction would be compensated for by the time saved in 
multiple extractions and solvent evaporation The use of excess sodium carbonate in the 
initial steps of the extractions was found to be a reliable method by which a reproducible 
pH of 10 could be obtained. Ether and chloroform offered advantages over most of the 
other solvents because they are polar, volatile and largely immiscible with water. The 
HCVchloroform proved satisfactory for the extraction of acid drugs while for most basic 
drugs the Na2C03/ether procedure proved more efficient than the Na2C03/chloroform 
procedure. The extraction of barbiturates, with the exception of phenobarbital, from the 
sodium carbonate solution (pH approximately 10) was possible in spite of barbiturates 
being classified as acidic drugs. 
A novel single-step extraction method for TLC identification, which was capable of 
testing a wide variety of drugs of abuse was described by Kaistha et aL (1975). The 
technique involved the use of paper loaded with cation-exchange resin. This paper was 
soaked in 20 - 50 ml of urine. After 60 minutes the paper was rinsed with deionized 
water. This paper was then put into a screw-capped jar containing ammonium chloride -
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ammonia buffer solution (pH 10), and chloroform-isopropanol (3 : I) . After shaking, the 
organic phase was transferred to a centrifuge tube with sulphuric acid (0.5%) in 
methanol. The solvent was then evaporated and the residue redissolved in methanol and 
spotted on a TLC plate. 
A procedure for the fast screening of urine samples was described by Dadisch et al. 
(1977). The extraction procedure included the use of a high (NH4hS04 and ethyl 
acetate concentration (pH 9.5), which enabled the extraction of most of the basic drugs. 
Back -extraction with 10% tartaric acid and re-extraction at pH 9.5 purified the extract 
and concentrated the sample up to 75 times. 
The use of bonded phase silica as an extraction medium has been reported for a number 
of drug classes from serum and urine. Ford et al. (1983) demonstrated the applicability 
of octadecylsilane (ODS) bonded silica for the extraction of acidic drugs from whole 
blood for screening purposes. They used GeINPD and GeIMS (mass-spectrometry) for 
the identification of the compounds extracted. The method reduced the problems 
associated with co-extracted lipids, required only a small volume of organic solvents and 
provided acceptable recoveries well into sub-therapeutic ranges for many acidic drugs. 
Diazomethane, for methylation, was used in the final step. 
The recovery of 28 acidic drugs from water and plasma was investigated by :Bailey and 
Kelner (1984) using hexane, diethyl ether, toluene, n-butyl chloride and chloroform as 
extraction solvents. The drug classes investigated were barbiturates (9), sulphonarnides 
(3), diuretics (4) and other acidic drugs (12). The pH of each sample was adjusted with 
I N HCl to between pH I to 2 and the samples were then extracted with the five 
different solvents. Anhydrous sodium sulphate was used to dehydrate the ether and 
chloroform extracts after the organic layer was separated from the aqueous phase. The 
organic phase was evaporated and the resulting extracted residues reconstituted in 2ml 
IN NaOH, and then scanned spectrophotometrically from 200 to 400 nm against its 
31 © Central University of Technology, Free State
corresponding blank. As drug classes, the barbiturates, sulfonamides and diuretics were 
best extracted from both water and plasma by diethyl ether. 
A one-step clean-up procedure was used by Chan and Chan (1 984) in their extraction 
procedure for acidic and neutral drugs in post-mortem blood. After acidifying the 
sample, ethyl acetate was used as organic solvent. The organic phase was then dried and 
the residue reconstituted in methanol. The relative retention times of various drugs were 
determined by HPLC using a multi-step linear gradient elution program of acetonitrile 
and phosphtae buffer (10-3 M, pH 3.2). The internal standard used was tolylbarbital 
511g/ml. The concentrations of the other drugs were 511g/ml or 1011g/ml, except for 
salicylic acid which was 50I1g/ml. Forty-eight drugs and metabolites were screened by 
the authors using this HPLC procedure. 
Three isocratic eluents prepared from isopropanol, formic acid and an aqueous 
phosphate buffer have been used by Stevens and Gill (1986) for the HPLC analysis of 
analgesic and non-steroidal anti-inflammatory drugs in forensic toxicology. These 
eluents were used to chromatograph more than 40 analgesic drugs on an ODS silica 
HPLC column. To whole blood samples was added blood precipitant (diluted perchloric 
acid containing the internal standard, N-propionyl-p-aminophenol) and the sample 
vortexed briefly. After centrifugation, 5 ~l of the clear supernatant was injected onto the 
HPLC system. 
Salicylic acid and paracetamol together with a wide range of other anti-inflammatory 
drugs were analysed by Moore and Tebbett (1987). Bond-Elute® solid phase extraction 
(SPE)columns, containing C8 packing material were used for the extraction. The 
columns were activated by washing with methanol followed by O.OIM hydrochloric acid. 
After the blood sample was applied to the column it was washed with distilled water 
before elution with methanol : 1% aqueous NH40H : acetonitrile (50 : 30 : 20). The 
eluent was evaporated to dryness and the residue was redissolved in methanol. These 
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samples were then injected onto a HPLC column. To prevent SPE column blockage, 
blood samples were uItrasonicated before analysis. 
A comprehensive screening procedure using HPLC for the detection of 23 diuretics in 
urine was developed by Cooper et al. (1989). Two aliquots of 2ml urine samples were 
extracted separately with ethyl acetate under acidic and basic conditions. The acidic and 
basic extracts were pooled, evaporated to dryness and reconstituted in methanol 
containing the external standard, l3-hydroxymethyl theophylline. The acidic ethyl acetate 
extract was shaken with 5% aqueous lead acetate solution to remove urinary pigments 
and other extraneous materials before combining it with the basic ethyl acetate extract. 
Gradient elution HPLC was used to separate the extracted components detected with a 
diode array detector. 
A rapid screening method for basic drugs using HPLC and diode array detection was 
published by Logan et al. (1990). The system involved cation exchange solid-phase 
extraction for 100 basic drugs and their metabolites, and gradient elution HPLC with 
diode array detection.. The solid-phase extraction was performed on 1-ml Bond Elute 
strong cation exchange (SCX) columns. The method was compared with an existing 
liquid-liquid extraction/capillary GC procedure and was at least as effective for 
extracting and identifYing basic drugs. 
A single-column solid-phase extraction procedure was developed for the isolation of 
acidic, neutral and basic drugs from whole blood by Chen et al. (1992). In this study, the 
use of Bond Elute CertifY mixed-mode SPE columns, which contained both hydrophobic 
and cation functional groups for the extraction of a broad selection of acidic, neutral and 
basic drugs from plasma within one run, was investigated. The drugs were eluted in two 
groups, according to their physical properties and analysed by gas chromatography. The 
column was preconditioned with methanol, followed by phosphate buffer (pH 6.0). 
After the sample application, the column was washed with deionized water, and a pH 
adjustment ( acidic) was made. Elution of the different fractions was then made with 
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acetone : chloroform (I 1) followed by 2% ammoniated ethyl acetate. Most of the 
acidic and neutral drugs were eluted with the acetone : chloroform and the basic drugs 
were present in the ammonia ethyl acetate eluent. Three different precipitation methods 
were investigated but the combination of sonication and dilution was found to be the 
most effective and preferred technique for the pretreatment of whole blood. 
Another class-independent drug screening procedure suitable for the use in clinical and 
forensic toxicology was developed by Drummer et al. (1993). This gradient-elution 
high-performance liquid chromatography and diode array detection method is capable of 
detecting and identifYing therapeutic and toxic amounts of; barbiturates, anti-
convulsants, diuretics, non-steroidal anti-inflammatory drugs, sulphonylurea anti-diabetic 
drugs, theophylline and analgesic drugs. Standards were prepared in groups representing 
concentrations likely to be encountered at the high end of the therapeutic range. 
Samples (blood) and standards were added to polypropylene micro extraction tubes 
followed by acetonitrile containing p-methylphenyl phenylhydantoin as internal standard 
to precipitate proteins. The samples were properly mixed and allowed to stand for 10 
minutes and then centrifuged at high speed (± 10 OOOg) for 10 minutes. An aliquot of 
the supernatant (20fll) was then injected into a HPLC. 
At the end of the chromatographic procedure the relative retention times (RR T) of peaks 
were calculated and the components identified based on their RR T and UV spectra. An 
advantage of this method was that no selective extraction procedure was used to clean 
up the blood samples thus allowing any substance, if present in sufficiently high amounts, 
to be detected. 
2.3 Recovery 
Except for immunoassays, most analytical toxicology procedures require isolation of the 
drugs from either an aqueous or biological matrix (usually plasma or urine) prior to the 
actual measurement. A very important aspect of any isolation procedure is the extent of 
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the recovery of the analyte from the matrix since this will often determine whether a 
component will be detected especially when one deals with some of the modern potent 
drugs. Most published analytical procedures usually contain a report of recovery and in 
this respect all the extraction procedures mentioned earlier have been reported on in the 
publications cited. Since no single extraction procedure can be singled out as being the 
preferred procedure for all drugs, the choice of isolation procedure used is often dictated 
by parameters such as availability, convenience, speed, etc. In the case of emergency 
toxicology, for instance, where one often deals with overdoses of drugs, speed of 
isolation is more often than not, more important than good recovery. 
2.4 Relevance of cited literature with the current investigation 
From the cited literature it is clear that HPLC-based screening procedures are widely 
used for a large number of drugs. However, many of the published screening procedures 
were designed to detect a relatively small range of a specific group of drugs and 
therefore did not suit our need for a broadly based toxicological screening procedure for 
acidic, neutral and amphoteric drugs. 
Most of the recent studies involving HPLC made use of solid phase extraction 
procedures while liquid-liquid extraction was extensively reported in earlier publications 
describing mainly GC and TLC screening techniques. Due to the high cost of solid phase 
extraction and our favourable experience with liquid-liquid extraction, it was decided to 
use liquid-liquid extraction in this study and to incorporate a lead acetate washing 
procedure to remove many of the endogenous pigments, co-extracted from urine, into 
the organic phase. The lead acetate washing procedure was previously developed and 
successfully applied to the detection of diuretics in urine. 
Of the many chromatographic gradient elution mobile phase systems published, the 
combination of acetonitrile and tetraethyl ammonium phosphate containing buffer 
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appeared to be the most generally used, and was therefore chosen for the development of 
this screening procedure as well . 
The general acceptance of the diode array detector as an useful instrument for obtaining 
UV spectra "on-the-f1y" for comparison with spectra stored in a spectral library, using 
established search algorithms, made the decision to use such a detector an automatic one. 
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Experimental 
3.1 Study Design 
CHAPTER 3 
In the light of the purpose of this study an isolation procedure yielding a final extract 
which was clean enough to be analysed on a high-performance liquid chromatograph, 
was developed. For identification, a diode array detector was used in order to acquire 
UV spectra of eluting components which would be compared with UV spectra of drugs 
stored in a spectral library. In addition, it was envisaged that retention time data would 
be used in conjunction with the spectral data to aid in the unequivocal identification of 
the eluting components. 
Based on the literature survey a liquid-liquid extraction procedure was opted for and 
diethyl ether and ethyl acetate were chosen as the two extraction solvents to be 
investigated. Solid phase extraction was not considered as a viable option because of the 
cost of this procedure. 
In addition to the 20 analgesic and non-steroidal anti-inflammatory drugs, 40 drugs 
belonging to a wide variety of classes were included in this investigation since they were 
acidic, neutral or amphoteric compounds which could feasibly be extracted under the 
same conditions. Moreover, the possibility existed that they could have been 
encountered in the chromatograms during the screening of overdose cases. 
Once the screening procedure was set up, actual case studies were expected to 
contribute additional information to the database. This was especially envisaged with 
respect to metabolites and other compounds which were not amongst the original 
compounds selected for investigation at the beginning of the project. 
Samples received for toxicological screening were analysed and the resulting UV spectra 
compared with the spectra stored in the library. When new compounds were identified 
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in these case studies, their spectra were stored in the library along with the retention time 
data acquired. 
3.2 Equipment 
3.2.1 A Hewlett-Packard Model HPI090 liquid chromatograph, equipped with a 
PV5 gradient solvent delivery system and an autosampler, was used. 
3.2.2 The detector was a UVNIS diode array spectrophotometer detector 
(Hewlett-Packard 1040). The eluent was monitored at 210 nm and full 
spectra were recorded from 210 to 600 nm for each peak, making use of the 
peak-controlled spectral acquisition mode. A spectral library was acquired 
under local conditions for each compound examined. With the detector, 8 
different wavelengths could be followed at the same time till the end of a run. 
The following diode array detector signal and spectral acquisition parameters 
were applied. 
Signals A B C D E F G 
Sample (nm) 
Wavelength: 210 220 230 254 260 280 320 
Bandwidth: 30 30 30 30 30 80 80 
Reference 
Wavelength: 380 380 380 380 380 380 380 
Bandwidth: 100 100 100 100 100 100 100 
Store spectrum: Peak controlled 280 records acquired during run 
Threshold: 10mAU 
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Peakwidth: 
Stop time: 
Post time: 
3.2.3 
0.300 min. Sampling interval 2240 ms 
30.00 min. Spectrum range from : 210 nm 
5.00 min. To: 600 nm 
Data acquisition: Hewlett-Packard Pascal Chemstation consisting of an 
HP9000/300 computer, an HP IS3C disk drive and an HP VDU The 
Chemstation software allowed the creation of a spectral library of substances 
as well as the automatic comparison of experimental data with the library 
data (retention time and UV spectra). 
3.2.4 A Hewlett-Packard Think Jet printer and a model HP 7470A plotter were 
used for hard copy output. 
3.3 Materials 
3.3 .1 Pure drug substances were obtained from pharmaceutical companies. Stock 
solutions of these drugs were prepared at a concentration of I mg/ml in 
methanol. These methanolic solutions were stored in screw-capped 
scintillation vials in the refrigerator at a temperature of 2 - S 0c. 
3.3.2 A Phase Sep® SS ODSI (IS cm x 4.6 mm) column with a Perisorb® RP-IS 
guard column was used, both at ambient temperature. 
3.3.3 The mobile phase consisted of two component solutions A and B which were 
pumped and mixed by the solvent delivery system to produce the required 
mobile phase gradient: 
Mobile phase component A (MPCA): 30 g Tetraethylammonium hydroxide 
(20% solution in water) was diluted with water to about SOO ml, the pH 
adjusted to 2.S by the addition of S.S g H3P04 and the solution then made up 
to 1000 m I with water. To 900 ml of this solution, referred to as the TEAP 
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buffer, 100 ml acetonitrile was added and the resultant solution referred to as 
MPCA 
Mobile phase component B (MPCB): To 1 litre of acetonitrile, 100111 H3P04 
was added. 
A mobile phase gradient was used to increase MPCB from 30% at time 0 to 
50% at 30 min. (effectively increasing the acetonitrile content of the mobile 
phase from 40% to 60%). A re-equilibration time of 5 min. was allowed 
after each gradient run. The flow rate of the mobile phase was kept at 
1 mllmin. The 10% acetonitrile in MPCA was chosen to prevent mlcro-
orgarusm growth in the TEAP buffer while allowing gradients to be 
constructed starting with a lower percentage of acetonitrile when required, 
without having to make up a fresh solution ofMPCA. 
3.3.4 Lead acetate solution was prepared by dissolving 7.5g lead acetate in 150 mI 
deionized water. 
3.3 .5 All solvents used were HPLC grade except diethyl ether which was analytical 
grade and was distilled before use. The water used, was purified by a Mill-
Q filtration system to a resistance above 18 megaohm cm- I 
3.3.6 Internal standard solution A (ISA): 25 mg Flufenamic acid was dissolved in 
100 mI of mobile phase consisting of I part ofMPCA and I part ofMPCB. 
One hundred III of this solution was used in the final reconstitution of the 
samples analysed. 
Internal standard solution B (ISB): 25 mg Carbamazepine was dissolved in 
100 mI of mobile phase, consisting of 1 part ofMPCA and I part ofMPCB. 
One hundred III of this solution was used as the internal standard in the 
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recovery of groups 13 and 14 because the retention times of meclofenamic 
acid and flufenamic acid were identical. 
3.3 .7 10% H3P04 (112.35 ml ofa 89.0% H3P04 was made up to I litre). 
3.4 Extraction 
The stock solutions of the 60 drugs studied in the course of this project, were injected 
onto the HPLC one at a time, in order to determine their retention times in the system. 
Retention times were compared during the case studies with the urine of patients. To 
avoid having to perform the extraction experiment separately on each of the 60 
compounds, the drugs were combined into 14 groups of at least 2, and at most 8, 
components per group. These groups were selected on the basis of their different 
retention times ensuring good resolution for the different substances. 
Two ml drug-free urine samples were spiked for the extraction experiments with the 
various groups of components at a concentration of 25 Ilg / 2 ml for each component. 
This concentration was chosen for analytical convenience as well as to represent 
toxicologically relevant levels for most of the drugs tested. A reference standard was 
prepared by spiking 25 Ilg of each of the drugs in a specific group into an empty glass 
ampoule. The solvent was then evaporated under a stream of nitrogen. One hundred III 
of the mobile phase, containing 60% acetonitrile and the internal standard, was then used 
to reconstitute the standards to yield a concentration of 2.5 Ilg / 10 III of each 
component in the final injection solution. 
The extraction procedure to determine the recovery of each drug are presented in the 
following table. 
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1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
EXTRACTION 1 
2ml unne sample (B 14 centrifuge 1. 
tube) 
add 500!!1 10% H3P04 
add 5ml diethyl ether 
Shake by hand for 2 min. 
Centrifuge for 2 min. 
2. 
3. 
4. 
5. 
Transfer diethyl ether into a 10 ml 6 . 
ampoule 
EXTRACTION 2 
2ml urine sample (B 14 centrifuge 
tube) 
add 5ml ethyl acetate 
Shake by hand for 2 min. 
Centrifuge for 2 min. 
Transfer ethyl acetate into a 10 ml 
ampoule 
Add 2mllead acetate solution 7. Add 2mllead acetate solution 
Vortex for 2 min. 8. Vortex for 2 min. 
Centrifuge for 2 min. 9. Centrifuge for 2 min. 
10. Transfer diethyl ether into a 5ml 10. Transfer ethyl acetate into a 5ml 
ampoule ampoule 
II . Evaporate at -40°C under nitrogen II . Evaporate at -40 °C under nitrogen 
12. 
13. 
Reconstitute in 100 !!l mobile phase 12. 
( 60% acetonitrile) containing 1. S. 
13. 
Reconstitute in 100 !!l mobile phase 
(60% acetonitrile) containing 1. S. 
The lead acetate wash was performed to remove urinary pigments and other extraneous 
material from the extracts. Samples with a recovery lower than 10% were re-analysed 
without the lead acetate washing step to determine whether the low recovery could be 
due to the washing step. These samples were spiked in deionized water and extracted 
with ether. Lead acetate washing had an influence on the recovery of only two drugs, 
namely paracetamol and sulphacetamide. When the lead acetate wash was omitted, the 
recoveries for both these substances improved from 0% to ±30%. However, in several of 
the case studies, paracetamol was found in the urine of patients indicating that this 
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method can be used to detect paracetamol overdose. The sensitivity of the method 
varied from compound to compound. 
The following table represents the 14 groups of drugs studied, their retention times as 
well as their relative retention times with respect to flufenamic acid used as internal 
standard. 
The heading "Description" refers to the compound classes: A - Acidic, B - Basic, AM -
Amphoteric, and N - Neutral 
Group 1 Retention time Relative Description 
(min.) Retention time 
1. Mafenide 1.46 0.06 AM 
2. Paracetamol 2.10 0.09 N 
3. Sulphadimethoxine 480 0.21 AM 
4. Cinnamic acid 5.43 0.24 A 
5. Carbamazepine 6.94 0.30 N 
6. Bezafibrate 11.00 0.48 A 
7. Mefenamic acid 21.84 0.95 A 
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Group 2 Retention time Relative Description 
(min.) Retention time 
1. Sulphasomidine 1.98 0.09 AM 
2. Sulphathiazole 233 0.10 AM 
3. Sulphadoxine 3.63 0.16 AM 
4. Furosemide 5.67 0.25 A 
5. Alclofenac 9.02 0.39 A 
6. Sulindac 10.95 0.48 A 
7. Bumadizon 14.94 0.65 A 
8. Ibuprofen 17.28 0.75 A 
Group 3 Retention time Relative Description 
(min.) Retention time 
1. Sulphacetamide 2.36 0.10 AM 
2. Salicylic acid 3.84 0.17 A 
3. Tolmetin 9.10 039 A 
4. Probenecid 1202 0.52 A 
5. Flurbiprofen 15.50 0.67 A 
6. Indomethacin 18.12 0.78 A 
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Group 4 Retention time Relative Description 
(min.) Retention time 
1. Hydrochlorothiazide 2.51 0.11 AM 
2. Sulphamethoxazole 3.79 0.16 AM 
3. Ketoprofen 9.73 OA2 A 
4. Fenbufen 11.77 0.51 A 
5. Diclofenac 17A9 0.76 A 
Group 5 Retention time Relative Description 
(min.) Retention time 
1. Sulphapyridine 2.55 0.11 AM 
2. Benzoic acid 3.83 0.17 A 
3. Tiaprofenic acid 9.32 OAO A 
Group 6 Retention time Relative Description 
(min.) Retention time 
1. Sulphamoxole 2.59 0.11 AM 
2. Sulphafurazole 4.02 0.17 AM 
3. Naproxen 10.16 OA4 A 
Group 7 Retention time Relative Description 
(min.) Retention time 
I. Acetanilide 3.65 0.16 N 
2. Benzthiazide 7.16 0.31 AM 
3. Bisacodyl 12.30 0.54 B 
4. Glibenclamide 19.70 0.86 A 
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Group 8 
I. Acetazolamide 
2. Chlormezanone 
3. Chlorpropamide 
4. Cyciopenthiazide 
Group 9 
I. Caffeine 
2. Phenolphthalein 
3. Tolbutamide 
Group 10 
1. Phenformin 
2. Chlorarnfenicol 
3. Chlorzoxazone 
4. Acetohexamide 
Group 11 
1. Theophylline 
2. Clopamide 
Retention time 
(min.) 
2.08 
5.48 
6.87 
9.14 
Retention time 
(min.) 
2.67 
6.79 
8.26 
Retention time 
(min.) 
1.84 
3.76 
5.55 
8.59 
Retention time 
(min.) 
2.04 
4.26 
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Retention time 
0.09 
0.24 
0.30 
0.40 
Relative 
Retention time 
0.12 
0.30 
0.36 
Relative 
Retention time 
0.08 
0.16 
0.24 
0.37 
Relative 
Retention time 
0.01 
0.19 
Description 
AM 
AM 
A 
AM 
Description 
B 
A 
A 
Description 
AM 
A 
B 
A 
Description 
B 
AM 
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Group 12 
1. Ranitidine 
2. Aminophenazone 
3. Tetracaine 
4. Piroxicam 
5. Warfarin 
6. Niflumic acid 
Group 13 
1. Chlorothiazide 
2. Sulphamethoxydiazine 
3 .. Flufenamic acid 
Group 14 
1. Sulphamethizole 
2. Meclofenamic acid 
3.5 Case Studies 
Retention time 
(min.) 
1.63 
2.53 
431 
7.98 
12.99 
17.08 
Retention time 
(min.) 
2.29 
2.30 
22.40 
Retention time 
(min.) 
2.71 
22.22 
Relative 
Retention time 
0.07 
0.11 
0.19 
035 
0.58 
0.76 
Relative 
Retention time 
0.10 
0.13 
1.00 
Relative 
Retention time 
0.10 
1.00 
Description 
AM 
B 
B 
AM 
A 
A 
Description 
AM 
AM 
A 
Description 
AM 
A 
Urine samples received for toxicological screerung were extracted usmg extraction 
procedure 1 (diethyl ether extraction) described earlier. In the final reconstitution of the 
sample, before injection onto the HPLC column, the mobile phase containing 60 % 
acetonitrile without the internal standard, was used. This was done because the software 
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program used, did not make use of relative retention times in the final analysis of the data 
that are matched with data in its library. However, the use of an internal standard in the 
extraction of unknown samples is recommended since relative retention times are more 
reproducible than absolute retention times and this information could be of use for 
identification purposes when it is available for comparison with the library data. 
Moreover, during the recovery studies the peak area of the internal standard was shown 
to be reproducible enough to be used as an indicator of the quantitative extraction yield. 
In the event of the unknown sample containing the internal standard, this would probably 
be noticed because the internal standard peak area would be higher than normal. 
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CHAPTER 4 
Results and Discussion 
4.1 Chromatography 
The best chromatography results were obtained with a Phase Sep® ODS I column and 
mobile phase gradient constructed from TEAP buffer (pH 2.8) and acetonitrile. 
The following column and mobile phases were also investigated: 
Hewlett-Packard microbore column hypersil ODS 5 flm 100 x 2.1 mm. 
Mobile phase 1: 
MCPA: To 1 litre of 0.05 M KHZP04, 1 ml formic acid was added. 
MCPB: Isopropanol 
A mobile phase gradient was used to increase MCPB from 5% at time 0 to 65% at 
20 min. A re-equilibration time of 5 min. was allowed after each gradient run. The 
flow rate of the mobile phase was kept at 0.2 mllmin. 
The following problems were encountered with this system: 
(a) When the gradient reached 65% isopropanol, the column pressure increased 
rapidly. This was probably as a result of the increased viscosity or possibly 
due to precipitation of buffer salts in the mobile phase. This proved to be a 
problem as some of the tested drugs only eluted at 65% isopropanol. 
(b) Because of the viscosity of isopropanol, the HPLC system had difficulty to 
maintain the specified flow rate. 
49 © Central University of Technology, Free State
Mobile phase 2: 
MCPA: To I litre of 0.025 M KH2P04, I ml formic acid was added. 
MCPB: To 1 litre of acetonitrile, 1 ml formic acid was added. 
A mobile phase gradient was used to increase MCPB from 5% at time 0 to 65% at 
20 min. A re-equilibration time of 5 min. was allowed after each gradient run. The 
flow rate of the mobile phase was kept at 0.2 mVmin. 
The following observations were made: 
(a) The acetonitrile gave less problems than the isopropanol for maintaining the 
flow rate at 0.2ml/min. 
(b) The peak shapes were not acceptable and peaks tended to tail with poor 
resolution between some of the substances. 
Mobile phase 3: 
MCPA: To I litre of 0001 M KH2P04, 1% H3P04 was added to adjust the pH to 
3.2 
MCPB: To I litre of acetonitrile, 100 !-II H3P04 was added. 
A mobile phase gradient was used to increase MCPB from 30% at time 0 to 60% 
at 40 min. A re-equilibration time of 5 min. was allowed after each gradient run. 
The flow rate of the mobile phase was kept at 0.2 mVmin. 
The following observations were made: 
Although some of the peak shapes improved, the chromatography did not improve 
significantly. 
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4.2 Recovery 
The recovery of each drug was calculated by dividing the peak area ratio of drug / 
internal standard of each component after extraction from the urine by the peak area 
ratio of drug / internal standard obtained with the standard injection solution obtained as 
described above. Results are presented in table 1. 
Table 1: RECOVERY PERCENTAGES OF 60 DRUGS SEPARATED ON 
HPLC. THE EQUIPMENT USED AND PROTOCOL 
FOLLOWED DURING~IE!.AMd'R0f§P~ OCEDURE ARE 
EXPLAINED IN THE , EXrl\S ~,gPSR1,( "n~E. p .·W';: Of \ n ..... ;) 
';\ "u~ 1~~ " \\.~ '.N\KO~ 
Drug oJ.; Ree ,xem A'\ t: % p,ecovery 
. ( di~mYr.~thtrJ":'--=-IeiiiYI acetate) ,-
I. Acetanelide 89.6 84.8 
2. Acetazolamide o * 
3. Acetohexamide 38.8 55.2 
4. Alclofenac 69.8 84.6 
5. Aminophenazone 33.9 * 
6. Benzoic acid 23.8 54.0 
7. Benzthiazide 83.2 76.9 
8. Bezafibrate 60.7 62.8 
9. Bisacodyl 70.3 75.1 
10. Bumadizon 57.5 79.6 
1 1 . Caffeine o 38.6 
12. Carbamazepine 54.2 3.8 TECHNIKON OVS/OFS 
13. Chloramphenicol 73.1 * 1995 -05- 10 
51 © Central University of Technology, Free State
14. Chlormezanone 62.0 94.1 
15. Chlorpropamide 72.5 91.0 
16. Chlorothiazide 31.4 * 
17. Chlorzoxazone 83 .0 93 .1 
18. Cinnamic acid 41.6 58.9 
19. Clopamide 17.2 • 
20. Cyclopenthiazide 77.3 85 .2 
21. Diclofenac 63 .9 70.0 
22. Fenbufen 66.2 81.4 
23 . Flufenamic acid 67.7 82.5 
24. Flurbiprofen 75 .9 80.3 
25. Furosemide 20.1 68.5 
26. Glibenclamide 81.9 77.9 
27. Hydrochlorothiazide 17.3 • 
28. Ibuprofen 81T 84.2 
29. Indomethacin 71.8 80.3 
30. Ketoprofen 67.6 83 .2 
31. Mafenide 0 0 
32. Meclofenamic acid 64.0 66.7 
33 . Mefenamic acid 72.6 74.5 
34. Naproxen 74.9 82.0 
35. Niflumic acid 91.4 80.7 
36. Paracetamol 0 • 
37. Phenformin 0 * 
38. Phenolphthalein 84.3 45 .5 
39. Piroxicam 81.4 87.0 
52 © Central University of Technology, Free State
40. Probenecid 61.8 87.0 
41. Ranitidine 0 • 
42. Salicylic acid 15.5 48.7 
43. Sulindac 31.9 74.3 
44. Sulphacetamide 0 0 
45. Sulphadimethoxine 64.5 83.9 
46. Sulphadoxine 38.4 97.6 
47. Sulphafurazole 35.4 86.2 
48. Sulphamethizole 4.6 • 
49. Sulphamethoxazole 58.8 98.7 
50. Sulphamethoxydiazine 0 • 
51. Sulphamoxole 0 • 
52. Sulphapyridine 0 • 
53. Sulphasomidine 0 0 
54. Sulphathiazole 0 0 
55. Tetracaine 31.8 55.2 
56. Theophylline 0 • 
57. Tiaprofenic acid 78.7 84.0 . 
58. Tolbutamide 76.4 42.4 
59. Tolmetin 40.2 74.9 
60. Warfarin 91.7 91.2 
* Indicates that the ethyl acetate extracted background interference is too high to be able to identify 
the drug peak satisfactorily and to calculate the % recovery. 
The results in Table I indicate that, for most of the acidic drugs, diethyl ether as organic 
extraction solvent gave good recoveries. Ethyl acetate yielded better recovery results for 
the sulphonamide group. However, the latter proved to be problematic, because the high 
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background of endogenous peaks, found in normal urine, often interfere with these low 
retention time compounds. Washing of the extracts with lead acetate solution was found 
to be beneficial in so far as concentrations of these endogenous compounds were often 
reduced in the extracts without the yield of the drugs studied being adversely affected. 
On the basis of the results of the recovery studies, diethyl ether extraction followed by 
lead acetate washing of the extract was adopted as the standard isolation procedure for 
investigating all samples sent in for toxicological screening by HPLC in all the case 
studies reported in this project.. 
The chromatograms of blank urines and of the 14 drug groups analysed are presented 
numerically in Appendix I and the UV spectra of the 60 substances alphabetically in 
Appendix II. UV Spectrophotometric absorption data are tabulated numerically In 
Appendix III, and alphabetically in ascending order of peak maximas in Appendix IV. 
4.3 Case Studies 
In the discussions of the case reports which follow, the UV spectra of the unknowns are 
drawn in black while the matching spectra from the spectral library are drawn in red. 
The matched compound's name and its retention time as recorded in the spectral library 
data base are printed in red and the match quality, expressed as a percentage, is also 
indicated in each figure. 
Case 1 
A urine sample and plasma were received for toxicological screening after a 23 year old 
male patient was admitted to the casualty department with a suspected overdose of 
paracetamol and tricyclic antidepressants (TAD). Plasma paracetamol and TAD levels 
were requested and gave the following results: no paracetamol could be found while the 
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TAD level was 270 nglml. These tests were performed using fluorescence polarization 
immuno-assay (TDX). 
An extract of the urine was subjected to HPLC and Fig. 1 represents the chromatogram 
of the sample analysed. The two major peaks at 4.36 min. and 9.61 min. with spectral 
matches illustrated in figures 1 a and 1 b were both identified as naproxen (match qualities 
of 99.3 and 99.9% respectively) using the library search function. However, only the 
peak with retention time of 9.61 minutes matched the retention time of naproxen and 
was therefore identified as naproxen. The good spectral match with naproxen, of the 
peak with retention time of 4.36 minutes, indicates that this component was probably a 
metabolite of naproxen. The data for this peak were therefore entered provisionally for 
future reference as naproxen metabolite data into the spectral library; information which 
can be corroborated by performing an administration study with naproxen at some 
convenient time, or by observing whether the same component is again present in the 
next case involving naproxen. This type of additional metabolite pattern data increases 
the identifYing power of any drug screening procedure considerably and represents the 
most compelling reason for a toxicology unit to set up its own spectral library for 
screemng purposes. 
Paracetamol could not be found in this urine sample. The presence of naproxen and the 
absence of paracetamol in the sample underlines the unreliability of information often 
volunteered by patients treated for intentional drug overdoses in the casualty room. 
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Case 2 
This case represents the data obtained from a 27 year old female patient who had 
apparently taken an overdose of Tegretol® (carbamazepine) and Brufen® (Ibuprofen). 
Plasma and urine were received for toxicological screening. A carbamazepine plasma 
level of 13.0 !-(g/ntl was determined by TDX .. 
Seven peaks were observed in the chromatogram of the urine extract (fig. 2). Of these, 
no less than four displayed very similar UV spectra (fig. 2a - 2d) and all matched the 
spectrum of ibuprofen very closely while only the peak with the retention time of 16.77 
minutes matched the retention time of ibuprofen. Just as in case 1, this component was 
therefore identified as ibuprofen while the other four components were agam 
provisionally added to the spectral library as ibuprofen metabolites. The relative 
retention times of these four components with respect to ibuprofen were 0.243, 0.265, 
0.306, and 0.371. That these were indeed metabolites of ibuprofen was corroborated in 
another case involving ibuprofen (case 13) in which peaks with relative retention times of 
0.241,0.265, and 0.307 with respect to ibuprofen were also observed. The absence of 
the peak with relative retention time of 0.371 in case 13, indicates differences in the 
metabolite patterns between subjects which are not uncommon. 
The peak with retention time of 6.92 minutes was identified as carbamazepine on the 
basis of the perfect spectral match illustrated in fig. 2e as well as on the basis of matching 
retention times. 
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ease 3 
This sample was collected from a 44 year old comatose female patient with the history of 
a benzodiazepine and alcohol overdose. Although blood and urine were sent to the 
laboratory, the clinicians only requested plasma benzodiazepine and ethanol levels. The 
benzodiazepine level was 21 14 ng/ml and the ethanol level 190 mg %, which indicated a 
severe poisoning. The urine sample was also extracted and subjected to HPLC I UV-
spectral screening on the next day and the chromatogram (fig. 3) obtained showed two 
peaks at 2.45 min. and 6.78 min. which were identified as hydrochlorothiazide (fig. 3a, 
99.9 % match) and carbamazepine (fig. 3b, 99.7 % match). These results once again 
stressed the importance of performing a thorough general toxicological screening even 
when the cause of the patient's condition could apparently be explained on the basis of 
results already at hand. This is especially so when a patient is comatose since the 
treatment could be profoundly influenced by the presence of some other drugs which 
may not have been identified. 
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Case 4 
A severe paracetamol overdose case was admitted to the hospital. This 21 year old 
female patient had reputedly ingested 100 Paraded® (paracetamol) tablets (500 mg) 
approximately 4 hours before she was admitted. The paracetamol plasma level analysed 
on the TDX gave a level of 332 Ilglml. The chromatogram obtained when the extract of 
a urine sample was injected on the HPLC gave a very high absorbance (greater than 
2000 mAU) for a peak with a retention time of 2.07 min. in spite of the fact that 
paracetamol is extracted with a very low yield as shown in the table of recoveries 
presented in chapter 3. Because no UV -spectra could be obtained as result of the high 
absorbance, the sample was diluted 4 times (300 III 60% mobile phase was added to the 
100111 that is normally used to dissolve the sample in), and re-injected. Fig. 4 is the 
chromatogram obtained with the second injection after the sample was diluted. Only one 
peak with a retention time of 2.07 min. and an absorbance of 800 mAU at 210 nm was 
observed. A 100% match was found for paracetamol as indicated in fig. 4a. This, 
together with the correct retention time, confirmed the result of the plasma level analysed 
on the TDX and proves that paracetamol overdoses can be easily detected using this 
procedure notwithstanding the poor recovery with the extraction procedure. 
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Case 5 
A 24 year old female patient, with a history of a massive overdose of a mixture of 
medications, died shortly after arrival at the hospital. She left a letter, to indicate that she 
had taken the following medications: 100 Betapyn® (4S0 mg paracetamol, 8 mg codeine 
phosphate), 100 Stemetil® (5 mg prochlorperazine), 70 Voltaren® ,(25/S0 mg 
diclofenac sodium), 30 Panado® (SOO mg paracetamol) and 20 Prozac® (20 mg 
fluoxetine HCl) tablets. The deceased, who was apparently a nursing sister, also 
indicated that she had injected herself with 10 ampoules Avafortan®. 
Urine, blood and stomach contents were collected and sent to the laboratory for 
toxicological screening. Fig. S represents the chromatogram obtained with the extract of 
the urine sample which was analysed on the HPLC. Two major peaks could be observed 
on this chromatogram with retention times of2.09 and 3.70 min. The strong absorbance 
of the two components indicated that a high concentration of these compounds could be 
present. The library search for the peak at 2.09 min. revealed a 100% match for 
paracetamol (fig. Sa). The peak at 3.70 min .. gave a good match of 99% for salicylic 
acid (fig. Sb) although the peak maxima of the UV spectra differed quite substantially. 
The same phenomenon, which would be worth investigating more closely at some stage, 
was observed for salicylic acid on several other occasions. Plasma levels of both drugs 
were analysed using the TD X analyser and both were confirmed with concentrations of 
326 !!g/ml for paracetamol and 678 !!g/ml for salicylic acid. 
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Case 6 
A urine sample, analysed by gas chromatography for the presence of drugs of abuse 
revealed the presence of trimethoprim. The presence of trimethoprim, which is normally 
found in combination with sulphamethoxazole led to the analysis of the sample on the 
HPLC in order to determine whether this sulphonamide drug was indeed present in the 
urine sample. 
One peak with a retention time of 3.60 min. was present in the HPLC chromatogram 
(fig. 6) of the urine extract. The library search of the compound gave a 95 .0% (fig. 6a) 
match for sulphamethoxazole. Although the retention time of the peak correlated well 
with that of sulphamethoxazole, the UV spectra did not give a match as well as one 
would have expected. In the light of the poor match it was decided to investigate the 
possibility that our pure substance, which was used as reference standard and of which 
the spectrum was stored in the library, could have changed during storage. A solution of 
sulphamethoxazole, prepared from a tablet ofBactrim® and analysed on the system gave 
a peak with a retention time of 3.76 min., which matched sulphamethoxazole 100% 
indicating that the spectrum stored in the library was correct. Another possibility was 
that the peak at 3.60 min. in the sample could contain an impurity or a metabolite of 
sulphamethoxazole co-eluting with sulphamethoxazole. Using the purity check facility of 
the diode array detector software, the peak was shown to be impure. 
Thus, to investigate the possibility of co-eluting peaks, it was decided to change the 
mobile phase gradient to see whether a separation of such substances could be effected. 
The gradient used, was MPCB from 0% to 50% over a period of 30 minutes (effectively 
increasing the acetonitrile content of the mobile phase from 10% to 60% in this time 
period compared with the standard change from 40% to 60% over the same time 
period). The flow rate and all other conditions remained the same as for previous 
samples analysed. Fig. 6b represents the chromatogram obtained when the sample was 
run on the new mobile phase gradient. Two major peaks with retention times of 12.32 
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and 14.49 minutes were obtained. This chromatogram clearly demonstrated that two 
peaks was co-eluting at 3.60 min. in the previous chromatogram (fig. 6). The UV-
spectrum of the peak at 12.32 min. now gave a 99.8% match for sulphamethoxazole 
(fig. 6c) while the peak at 14.49 min. gave a 73 .0% match for sulphamethoxazole (fig. 
6d). The similarity of the UV spectra suggested that this second peak could have been a 
metabolite of sulphamethoxazole and the data were therefore stored as such for future 
reference in the spectral library. This assignment was corroborated by the presence of 
the same pair of peaks in case report 9. 
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Case 7 
A 17 year old female patient had taken an overdose of Aspirin® (acetylsalicylic acid), 
approximately 5 hours before urine and plasma were collected for analyses. A plasma 
level of 229 ~g!ml was found for salicylic acid on the TDX. Fig. 7 represents the 
chromatogram of the extract obtained by HPLC. Fig. 7a presents the match found 
(100%) for one of the metabolites of acetylsalicylic acid, namely salicyluric acid at 2.71 
min. and a 99.4% match was found for salicylic acid, 3.62 min. (fig. 7b). The retention 
times also correlated well with the retention time of these two compounds. 
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Case 8 
Urine from a 28 year old female patient was sent to the laboratory for toxicological 
screening. Gas chromatographic screening for basic drugs revealed meprobamate and 
codeine. Since these two drugs could be found in combination with other analgesics, an 
HPLC-screening was also performed on the urine sample. The chromatogram obtained 
(fig. 8) indicated that only small peaks were present of which the two peaks at 2.09 and 
5.40 min. gave proper UV -spectra. A 99.5% match for paracetamol (peak at 2.09 min.) 
and a 99.9% match for furosemide (peak at 5.40 min.) were found, once again 
emphasising the utility of using a broadly based screening procedure rather than the 
narrow target compound analyses which are presently so commonly carried out in 
laboratories which claim to be toxicology laboratories. 
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Case 9 
A patient with a suspected overdose of analgesics and antibiotics was admitted to the 
casualty department. This 21 year old male patient took the medication approximately 6 
hours before the sample was collected. 
With the initial chromatogram that was obtained, the peak with retention time of 3.69 
min. gave an absorbance reading above 2000 mAU at 210 nm. This high absorbance 
also had the effect that a proper UV -spectrum for this peak could not be obtained. The 
sample was therefore diluted three times (200~1 of a 60% mobile phase was added to 
100~1 in which the sample are normally dissolved). Fig. 9 represents the chromatogram 
after the sample was re-injected. Four peaks gave acceptable UV-spectra with which 
spectral library searches could be made. The peak at 2.08 min. gave a 100% match for 
paracetamol (fig. 9a). The peak at 2.73 gave a good match of99.8% for salicyluric acid 
(fig. 9b). 
The next two peaks at 3.11 and 3.69 min. indicated the possible presence of 
sulphamethoxazole with matches of 98.0% (fig. 9c) and 91.0% (fig. 9d) for 
sulphamethoxazole respectively. In the light of the previous results obtained with case 6, 
it was decided to rerun this sample with a gradient of MPCB from 0% to 50% over a 
period of 30 minutes (effectively increasing the acetonitrile content in the mobile phase 
from 10% to 60% over 30 min.). Fig. ge is the chromatogram of the rerun with the new 
gradient. Paracetamol now had a retention time of 4.85 min. with a 100% match and 
salicyluric acid gave a retention time of 9.85 min. with a 99.8% match. The absorbance 
curve of the peak at 10.72 gave a 98% match for sulphamethoxazole. This peak 
corresponds to the peak at 3.11 min. of the previous chromatogram (fig. 9). Because of 
the similarity to the spectrum of sulphamethoxazole, these data were tentatively assigned 
to a metabolite of sulphamethoxazole. 
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In addition, the peak with retention time of 3.69 minutes was now resolved into two 
peaks, with similar retention times as were observed in case 6. The UV -spectrum of the 
peak at 12.39 min. gave a 99.7% match for sulphamethoxazole (fig. 9f) while the peak at 
14.55 min. gave a 72.9% match for sulphamethoxazole (fig. 9g) corroborating the 
findings with sulphamethoxazole in case 6. A paracetamol plasma level of 41. hlg/ml 
was found on the TDX which confirmed the presence of the paracetamol. 
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Case 10 
Twenty Anadin® (acetylsalicylic acid) tablets were taken by a 26 year old male patient 
approximately 6 hours before urine and blood samples were collected for analyses. Fig. 
10, displaying 3 major peaks, represents the chromatogram which was obtained with the 
urine extract assayed by HPLC. Fig. lOa is the UV-spectrum of the peak at 2.23 min. 
This spectrum correlated well with a published spectrum of gentisic acid, a metabolite of 
acetylsalicylic acid. The spectral data were therefore stored under gentisic acid in the 
spectral library data base pending corroboration at some later stage. Fig. lOb is the 
spectrum for the peak at 2.73 min. giving a 100% match for salicyluric acid. A 98.8% 
match was found for salicylic acid (fig. IOc). Here, once again, the absorbance maxima 
did not correlate as well as was observed for other compounds. Analysis of a plasma 
sample of this patient on the TDX gave a salicylic acid plasma level of 450J.lglml, 
indicating a moderate poisoning with salicylic acid 
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Case 11 
A 27 year old male patient took a suspected overdose of paracetamol. The 
chromatogram obtained by HPLC of a urine extract (fig. 11) displayed one peak with a 
retention time of 2.06 min. The absorbance spectrum of this peak gave a 100% match 
for paracetamol (fig. Ila). The plasma paracetamollevel was SI.Ollglml, as analysed on 
the TDX. 
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Case 12 
A 38 year old female patient was seen at the casualty department with the history that 
she had taken various tablets in an overdose. In a gas chromatographic screening for 
basic drugs, cyclizine, pseudo-ephedrine and nicotine were identified. 
Fig. 12 represents the chromatogram of the urine screening for acid and neutral drugs 
run on the HPLC. : Salicyluric acid (2.74 min.; 99.8% match; fig . 12a), salicylic acid 
(3.76 min.; 99.8% match; fig. 12b), and ibuprofen metabolite (4.08; 100% match; fig . 
12c) were identified with the library search. The spectrum of the ibuprofen metabolite 
correlated well with previous spectra and retention times of a metabolite of ibuprofen 
found in cases 2 and 13 . This case therefore represents the identification of the ingestion 
of a specific drug from its metabolite data and not that of the parent substance. An 
indication of the presence of the parent substance could be observed in the 
chromatogram (small peak at about 16 min.) but the peak was too weak for a 
satisfactory UV -spectrum to be obtained for identification by spectral library search. 
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Case 13 
Ibuprofen, (16.83 min.; 99.8% match; fig . 13d), was found in a urine sample sent in for a 
barbiturate screening. The chromatogram (fig. 13) also displayed peaks at 4.05, 4.46 
and 5.16 min. These peaks gave relative retention times with respect to ibuprofen of 
0.241 , 0.265 and 0.307. These relative retention times correlated well with the data 
discussed in case report 2. The matches found with the library search are presented in 
fig. 13 a-c. The noise on the UV-spectra is due to the low concentration of these 
substances and probably indicates that a therapeutic dose of ibuprofen was involved here 
and not an overdose as was taken in case 2. 
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Case 14 
A urine sample was sent in with the request to screen for the presence of diuretics . The 
sample was collected from a female patient who was suspected of abusing diuretics. Fig. 
14 represents the chromatogram obtained by means of HPLC-screening. Only one peak 
with a retention time of 2.44 min. gave a satisfactory UV-spectrum. The 99.9% match 
found for hydrochlorothiazide (fig. 14a) confirmed the clinical diagnosis. 
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Case 15 
Fig. 15 represents the chromatogram of an extract of urine from a patient taking 
therapeutic doses of ketoprofen. Fig. 15a shows the match found for ketoprofen 
(99.9%) for the peak with a retention time of 9.39 min., which indicates that the method 
will have no difficulties in picking up ketoprofen in an overdose situation. The peak at 
6.00 min. gave no satisfactory UV-spectrum and could not be identified. 
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Case 16 
A medication sample was sent to the laboratory for analysis by a local clinician. This 
medication was dispensed by another clinician for treatment of an overweight patient. 
The patient had severe side-effects and this laboratory was consulted to find out what the 
active ingredients of the medication were. 
On gas chromatographic screening for basic drugs, norephedrine and caffeine were 
identified. Fig. 16 is the chromatogram obtained from the HPLC-screening of a 
methanol solution of the medication.. Four major peaks were observed which were 
identified as hydrochlorothiazide (2.48 min.; 99.9% match; fig. 16a), caffeine (2.70 min.; 
99 .8% match; fig. 16b), benzoic acid (3.81 min.; 100% match; fig. 16c), and 
phenolphthalein (6.65 min.; 100% match; fig. 16d). 
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Case 17 
A 17 year old female was admitted to hospital with the history that she had taken an 
overdose of her grandfather's medication. Her grandfather is an epileptic and the 
laboratory was asked to screen for anti-convulsants. Blood and stomach contents were 
sent to the laboratory for analysis. Since a urine sample was not obtained, 1 ml of the 
stomach contents was used in the HPLC-screening. The same procedure as for the urine 
extraction, was followed . Fig. 17 represents the chromatogram obtained with the 
HPLC-screening performed on the stomach contents. Three major peaks were observed. 
The peak at 2.01 min. gave a 100% match for theophylline (fig. 17a). The theophylline 
plasma level, determined after theophylline had been identified in the stomach contents, 
was 50 J.lg/m1 (TDX) which is in the highly toxic range. 
The peak with a retention time of 5.31 min. did not give an UV -spectrum with much 
detail but, because the possibility of anti-convulsants was indicated, the peak match of 
99.9% with a spectrum of amylobarbitone was considered important enough to confirm 
the presence of amylobarbitone by GC-MS. A plasma amylobarbitone level of 7.0 J.lg/m1 
was found, using gas chromatography with nitrogen/phosphorus selective detection. The 
peak at 6.91 min. gave a 100% match for carbamazepine, another anti-convulsant (fig. 
17c). The carbamazepine plasma level was found to be 5.1 J.lg/ml on the TDX. 
This case again illustrates the importance of proper toxicological screening and that 
clinicians should not only rely on the history that is given by the patient or accompanying 
persons. Had the clinician's request for target screening for anti-convulsants only, been 
heeded, carbamazepine and possibly amylobarbitone would have been identified and 
theophylline would certainly not have been detected. The clinician would probably have 
been satisfied that the patient's condition was due to an overdose of amylobarbitone with 
the plasma level of carbamazepine being in the lower therapeutic range. Fortunately the 
patient was probably protected against the potentially lethal concentration of theophylline 
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by the presence of the two anti-convulsants, and had the presence of theophylline not 
been detected, nobody would have been any the wiser. 
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4.4 General discussion 
The liquid-liquid extraction with diethyl ether, as organic solvent, followed by the lead 
acetate wash resulted in a clean extract with a minimum of endogenous compound 
interference with the chromatography of the drugs studied. The extraction yields were 
good for a wide range of compound types, illustrating the universal applicability of the 
liquid-liquid extraction procedure compared with the solid phase extraction which is 
often quite specific. This specificity of the solid phase extraction procedure is of course 
an advantage when quantitative assay procedures are sought for specific drugs but not in 
the case of a general qualitative screening procedure. The lead acetate wash step did not 
adversely affect the extraction yield of any of the compounds tested. The cost of 
materials for the liquid-liquid extraction was a small fraction of what the costs of a solid 
phase extraction procedure would have amounted to. 
The mobile phase gradient elution system turned out to be as versatile as expected, 
yielding well-shaped peaks for all the drugs tested and even for a number of basic 
compounds which were identified in the course of some ofthe case studies. This feature 
warrants a study to investigate the applicability of this chromatographic system to basic 
drugs in general. 
Sixteen different substances, excluding their metabolites, were identified in the seventeen 
case reports described. The matches, ranged between 98.8 % and 100 % for the parent 
substances for which spectra of standards were stored in the spectral library. Matches of 
metabolites compared with the parent substances ranged between 73 .0 % and 100 %. 
The close resemblance between some of the metabolites and their parent substances was 
remarkable and was an indication that the differences in molecular structure must have 
been small or that the information content in some of the UV -spectra was rather limited. 
However, in combination with the retention times of the components, the identifications 
were always unambiguous. 
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Four metabolites of ibuprofen (structures unknown), one of naproxen (probably 
desmethyl naproxen), one of sulphamethoxazole (structure unknown) and three of 
acetylsalicylic acid (salicylic acid , salicyluric acid and gentisic acid) were detected and 
stored as metabolite data in the spectral library for future reference. Whenever such 
metabolites are detected in future case studies, the information will be stored in the 
spectral database to aid in future identifications. This kind of invaluable information can 
only be available for direct identification purposes when the screening procedure and the 
chromatographic and spectral data are generated in-house for reference purposes, which 
was the main aim of this project. An interesting observation was that, although 
carbamazepine was identified in three cases, the two major metabolites namely the 
dihydroxy metabolite and the epoxide metabolites were not detected. This aspect still 
requires investigation since there is no reason to believe that these metabolites are not 
extractable by the procedure used. 
Five additional compounds, not described in the case reports , were identified. These 
were tetracaine, bezafibrate, benzoic acid and caffeine. Tetracaine and benzoic acid were 
identified in a sample of a drug product handed in for identification. Although it is not 
the intention to broaden this screening procedure to include basic compounds, the fact 
that tetracaine, a basic compound, could be chromatographed and identified successfully, 
attests to the versatility of the chromatographic system for other than acidic and neutral 
compounds. The identification of bezafibrate was made in a urine sample of a patient 
who ingested normal therapeutic doses giving some indication of the sensitivity of the 
method. 
Stomach contents as biological sample, treated in the same way as the urine samples, was 
shown to be a useful medium for the extraction and identification of unknown substances 
and could be used if no urine is available. The use of stomach contents has the 
advantage that high concentrations of substances are normally present and sensitivity of 
the method would not be a problem. 
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For chromatographic resolution of low retention time compounds, such as the 
sulphonamides, a mobile phase gradient starting with 10% acetonitrile can be 
implemented whenever necessary and was in fact used in two cases to separate 
sulphamethoxazole from one of its co-eluting metabolites (case reports 6 and 9)with 
good results. The change to a different mobile phase gradient only requires a few 
keystrokes prior to the injection of the extract. 
The application of the developed screening procedure to several case studies has 
confirmed its utility in not only identifYing the series of compounds chosen as a core of 
standards, but also unknown compounds. In addition, the compounds tentatively 
identified as metabolites in some of the case studies will serve as very important 
additional corroborative evidence in similar cases in future. This is especially so with 
drugs which are metabolised to several major metabolites, producing a very distinctive 
metabolite pattern which makes the evidence of intake of that particular drug irrefutable. 
Only in one case investigated so far was a major component in the chromatogram not 
identifiable. It is possible that this component could have been a metabolite of 
ketoprofen but this will have to await verification either by way of an administration 
study or another overdose case involving ketoprofen. 
The results obtained with some of the case studies, in which unsuspected drugs were 
identified, confirmed our contention that all poisoning cases should be studied employing 
broadly based screening procedures rather than selective testing with commercially 
available immunoassay based quick tests. Such quick tests are very useful in cases where 
circumstantial evidence for the intake of a specific drug is very strong but they should 
never be employed to the exclusion of more general screening procedures. The case in 
which theophylline was detected in the urine and then quantified in the plasma using one 
of these quick tests clearly illustrated the proper use of these procedures. If this case had 
had a fatal outcome with theophylline not being detected there might well have been 
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some awkward questions to answer if it were detected during a judicial post-mortem 
investigation. 
The cumulated information which will be added to the spectral data base while this drug 
screening procedure is being used in future cases, will eventually constitute the real 
contribution of this developmental research project. 
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APPENDIX I 
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UV 3.625 ACETANILIDE 
228248288 ______ _ 
Mawl th enll) 
IN 8.577 AC£T_IDE 
2281148 ___ 328148 __ _ 
Maw' eM) 
IN 2 . 545 A!1INOPIlENRZONE 
_248 ____ 148 __ _ 
Nave' e,.) 
UV 2.099 ACETAZOUI1IDE 
228248_218 _____ _ 
Wawl tit enlt) 
IN 8. 919 fLCl.orn;AC 
228248 ___ 128148 __ _ 
MaWI f tit eM) 
IN 3.838 BENZOIC Aero 
228 248 _ 288 _ 328 .... 8 318 He _ 
Maw' tit eM) 
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• 
lee 
UV 7. 151! IlENZTHIAZIDE 
ZZB 2482GB ZBB lBB 320 340 369 388 40B 
H;a.velen th ( nlft) 
UV 12.283 8ISACOllYl. 
220 2482GB zaB see 320 349 3S9 389 ... ae 
Wave Ie" th (nil) 
UV 2.687 CAFFEINE 
229 240 268 288 390 329 348 3S9 389 ... as 
Wavel. th Cn.) 
IN 18.919 B£ZfFIBRATE 
228 248 26B 288 300 328 348 368 3S8 "'eB 
H ..... le" \:h (ma) 
UV lS.l!lH llUHADIZON 
22e 24e 2Se 28e 3ee 32e 34e 3Se 38e 4ee 
Havel"n th Cn.) 
UV 6. 955 CRRIIAHAZ£PIHE 
228 2482GB 288 398 328 348 3SB 388 .. ee 
Havelen th Cn.) 
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IN 3 . 78G CH.J)Rfl1PHEIUCOL 
22S 2<S 2GS 28S 3as 32S 3<S 3GS 38S <as 
Havtlle" th (n.) 
IN G.852 CH..ORPROPfI1IDE 
22S 2<S 2GS 2ea 3as 329 3<S 3GS 3ea <as 
Wawl th (n.) 
IN S. S 11 CH..ORZOXRZONE 
22S 2<S 2GS 28S 3aa 32S 3<S 3GS 38S <as 
Wavel. th (n.) 
229 2.e 269 ZSB aee 32B 349 3SB aBB 49B 
Wavele" tn Cn.) 
IN 2" 296 OLOROTHIRZIDE 
229 2482GB 288 lBB 32B 34e 3S9 a8e 489 
Wavela" th (n.) 
IN S. <39 CI_IC Aem 
229 249 269 289 388 329 348 368 388 49B 
Wavele" th Cn.) 
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3 
2 
UY 4. 247 CLOI'AItIIl£ 
228 248 268 288 3ee 328 348 368 388 488 
Haval." th Cn.) 
UY 17.776 DICLOFENAC 
228 248 268 288 3ee 328 348 368 388 4ee 
Haval th Cna) 
UY 23.292 FUFDft1IC ACID 
228 248 268 288 3ea 328 348 368 388 4ee 
Wavele th Cna) 
UY 9. 149 CYCLOPENlHIAZIDE 
228 248 268 288 3ee 328 348 368 388 4ee 
W ..vele" th Cna) 
UY 11 . 952 FENIIUF£N 
229 248 268 2S8 lee 328 348 36B 388 4ee 
Wavel. th Cn.) 
UY 15.588 FURBIPRIlFEN 
22B 248 26B 288 398 328 348 36B 388 480 
Havel. th Cn.) 
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FI.ROSEHIIl£ IN 19.674 GLlBENC1..R1IDE 
~~---~~~-- ~~---~~~--L-________________ ~"~.vo~I.~t~h~(n~.~)~ ______________ _"L ________________ ~"~.vo~l~.~n~t~h~(n~.~)~ ______________ ~ 
IN 2.496 HYIROOI.<lROTHIAZIIl£ 
228 248 2S8 288 388 328 348 368 388 488 
Navelsn th Cn.) 
IN 18.142 IHDOItETIR:IH 
, 3 
r., 
4 
3 
2 
IN 17.2"'4 IBI.JPROF'EN 
228 248 268 288 388 328 348 3S8 388 488 
Navel. th Cn.) 
IN 9.884 KETOPROFEN 
Z28 248 2Se 288 388 328 348 3S8 388 488 Z28 248 2S8 288 388 328 348 3S8 3B8 488 
L-______________ ~"~.~vo~l.~"'~th,CC(~n~.~) ________________ ~ ~ _________________ "~.~vo~le'n th Cn.) 
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228 248 268 288 3111 328 348 388 388 _ 
W ...... I th en.) 
IN 21.15" I1EFDfI1IC Rem 
LN 18.311 NIFWtIC Aem 
228 248 268 288 _ 328 348 388 388 4111 
Hawl th (n.) 
LN 23.112 I£Q.OFEIAnc Aem 
22B 24B 268 288 3111 32B 34B 3S8 388 4111 
Hawl. th (n.) 
LN IB.IS3 NRPROXEN 
228 248 268 288 3111 328 348 368 388 _ 
Maw I th (n.) 
228 248 268 288 3111 328 348 368 388 488 
Navelen th (n.) 
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IN 1.ln Pl£NFORItIN 
228 2'8 268 288 388 328 3'8 368 388 <88 
MI..,. I th (n.) 
IN 7.97' PIROXI~ 
228 2<8 268 288 388 32B 3'B 36B 388 .88 
Navel." tit en.) 
IN 8 . 787 PHENOlPIf1'HA.£IN 
22It Z.. _ 2U 3118 3D 3<8 31. 3U _ 
Nav.1 th (".) 
IN 11.79< PROliEllEcm 
Z2B 2'B 26B 288 388 32B 3.B 38B 388 <88 
M.wl th (n.) 
IN 3.988 SALICYLIC Rem 
Z2B 2'B 26B 288 388 32B 3'B 38B 388 <88 
WaYO I ttl (n.) 
© Central University of Technology, Free State
3 
UV II. III SlLINIlAC 
228 2411 268 211! 388 328 348 3G8 388 488 
Ma.,.) th eMl) 
UV 4. 715 !II.U'IIAIlIl£11«)X!I£ 
228 248 288 211! _ 328 3411 388 388 488 
Wawl '" eftll) 
UV 3.96 I Sl.l.P!fI'lAIZC 
228 248 268 288 388 328 348 368 388 488 
Wave1en th (n.) 
UV 2.361 SlLPlflC£TRltIIE 
228 2411 288 211! 388 328 348 368 388 488 
Mawl. \h (n_) 
UV 3.685 Sl1.I'HFIDOJ(IHE 
228 248 288 211! _ 328 348 388 au 488 
M ..... I. th (.) 
tN 2.'54 9.LPHRI£THIZOLE 
228 248 2S8 288 388 328 348 368 388 488 
Navel." 'th (n.) 
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UV 3.733 SULP!R1£THOXAZOLE 
228 248 268 2B8 388 328 348 36B 3B8 488 
Havale th (n_) 
UV 2.599 SI.IJ'IifI1OXOL 
228 248 268 2B8 388 328 348 36B aB8 488 
Maw I th (n.) 
228 248 268 268 3BB 328 348 3B8 3B8 488 
Wavel 'ttt (n.) 
228 248 268 2B8 388 328 348 368 3B8 488 
M ...... I." th (n.) 
228 248 268 2BB 388 328 348 368 aBB 488 
H • .,.I." th (n.) 
UV 2.352 !llJU'HRlliIRZCI.£ 
228 248 268 2BB 388 328 34B 3BB 388 488 
N • .,.le" th (n_) 
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uv 4.311 TElRACRlNE 
228 248 288 288 388 328 348 368 388 488 
".v.I. ih (n.) 
uv 9.371 TI~It Rc:ID 
228 248 288 288 388 328 348 388 388 488 
MI.WI' ih (n.) 
uv 9.251 TIlI..J£TIN 
228 248 288 288 388 328 34' 388 388 488 
N ...... I." \h Cn_) 
uv 2.ee4 TI£OPHYl.UNE 
228 248 288 288 3ee 328 348 388 388 488 
Wawlen th (n.) 
UV 8.224 TaLB.lTRHIllE 
228 24' 28' 288 388 328 a48 388 388 488 
M ..... I \h (n.) 
UV 13.878 ~ 
22' 248 288 288 aee 328 a48 Mavel \h (n.) 
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218 
218 
218 
220 
220 
224 
224 
226 
226 
226 
226 
226 
228 
ULTRAVIOLET SPECTROPHOTOMETRIC 
ABSORPTION DATA 
(Absorption maxima listed in numerical order of the strongest peak in the 
spectrum and subsidiary peaks in order of absorbance strength) 
A max (nm) SUBSIDIARY PEAKS COMPOUND 
286/344 Flufenamic acid 
234/274 Meclofenamic acid 
278/350 Mefenamic acid 
262 Ibuprofen 
266 Mafenide 
280 Benzthiazide 
270/316 Hydrochlorothiazide 
Chlormezanone 
278 Chlorothiazide 
248 Probenecid 
318 Ranitidine 
284/258/328 Sulindac 
275 Benzoic acid 
82 
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228 Bezafibrate 
228 300 Glibenclamide 
228 274 Phenolphthalein 
228 262 Tolbutamide 
230 270 Naproxen 
232 Chlorpropamide 
232 Clop amide 
232 274/342 Furosemide 
232 298 Salicylic acid 
234 Bumadizon 
234 Phenformin 
236 270 Cyclopenthiazide 
240 Acetanilide 
246 Acetohexamide 
246 Flurbiprofen 
246 Paracetamol 
256 Ketoprofen 
258 Aminophenazone 
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260 316 Indomethacin 
260 282 Sulphasomidine 
262 Bisacodyl 
264 Acetazolamide 
264 Sulphapyridine 
268 Sulphamethoxazole 
268 Sulphamoxole 
. 
270 Sulphacetamide 
270 Sulphadimethoxine 
270 Sulphafurazole 
270 228 Sulphamethoxydiazine 
270 Theophylline 
272 Caffeine 
272 Sulphadoxine 
274 Diclofenac 
276 Chloramphenicol 
276 216 Cinnamic acid 
278 Alclofenac 
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280 Chlorzoxazone 
280 Sulphamethizole 
280 272/304 Warfarin 
284 Carbamazepine 
284 Fenbufen 
286 334 Niflumic acid 
286 258 Sulphathiazole 
306 264 Tiaprofenic acid 
312 226 Tetracaine 
312 258 Tolmetin 
362 244 Piroxicam 
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ULTRAVIOLET SPECTROPHOTOMETRIC 
ABSORPTION DATA 
(Drugs listed in alphabetical order) 
COMPOUND A. max (nm) Relative Retention time 
Acetanilide 240 0.16 
Acetazolamide 264 0.09 
Acetohexamide 246 0.37 
Alclofenac 278 0.39 
Arninophenazone 258 0.11 
Benzoic acid 2281275 0.17 
Benzthiazide 2241280 0.31 
Bezafibrate 228 0.48 
Bisacodyl 262 0.54 
Bumadizon 234 0.65 
Caffeine 272 0.12 
Carbamazepine 284 0.30 
Chloramphenicol 276 0.16 
Chlormezanone 226 0.24 
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Chlorpropamide 232 0.30 
Chlorothiazide 226/278 0.10 
Chlorzoxazone 280 0.24 
Cinnamic acid 216/276 0.24 
Clopamide 232 0.19 
Cyclopenthiazide 236/270 040 
Diclofenac 274 0.76 
Fenbufen 284 0.51 
Flufenamic acid 218/286/344 1.00 
Flurbiprofen 246 0.67 
Furosemide 232/274/342 0.25 
Glibenclamide 228/300 0.86 
Hydrochlorothiazide 224/270/316 0.11 
I 
Ibuprofen 220/262 0.75 
Indomethacin 260/316 0.78 
Ketoprofen 256 042 
Mafenide 220/266 0.06 
Meclofenamic acid 21812741234 1.00 
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Mefenamic acid 218/278/350 0.95 
Naproxen 230/270 0.44 
Niflumic acid 286/334 0.76 
I 
Paracetamol 246 0.09 
Phenformin 234 0.08 
Phenolphthalein 228/274 0.30 
Piroxicam 244/362 0.35 
Probenecid 226/248 0.52 
Ranitidine 226/318 007 
Salicylic acid 232/298 0.17 
Sulindac 226/2581284/328 0.48 
Sulphacetamide 270 0.10 
Sulphadimethoxine 270 0.21 
Sulphadoxine 272 0.16 
Sulphafurazole 270 0.17 
Sulphamethizole 280 0.12 
Sulphamethoxazole 268 0.16 
Sulphamethoxydiazine 228/270 0.13 
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Sulphamoxole 268 0.11 
Sulphapyridine 264 0.11 
Sulphasomidine 260/282 0.09 
Sulphathiazole 258/286 010 
Tetracaine 226/312 0.19 
Theophylline 270 0.09 
Tiaprofenic acid 264/306 OAO 
Tolbutamide 228/262 0.36 
Tolmetin 258/312 0.39 
Warfarin 272/280/304 0.58 
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